| Year |
Citation |
Score |
| 2024 |
Chen X, Tsvetkov AS, Shen HM, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon HU, Galluzzi L, Luo S, Xu D, Gu W, Peulen O, Cai Q, Rubinsztein DC, ... ... Kroemer G, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. PMID 38442890 DOI: 10.1080/15548627.2024.2319901 |
0.311 |
|
| 2023 |
Pan H, Liu P, Zhao L, Pan Y, Mao M, Kroemer G, Kepp O. Immunogenic cell stress and death in the treatment of cancer. Seminars in Cell & Developmental Biology. 156: 11-21. PMID 37977108 DOI: 10.1016/j.semcdb.2023.10.007 |
0.337 |
|
| 2023 |
Kovatcheva M, Melendez E, Chondronasiou D, Pietrocola F, Bernad R, Caballe A, Junza A, Capellades J, Holguín-Horcajo A, Prats N, Durand S, Rovira M, Yanes O, Stephan-Otto Attolini C, Kroemer G, et al. Vitamin B is a limiting factor for induced cellular plasticity and tissue repair. Nature Metabolism. 5: 1911-1930. PMID 37973897 DOI: 10.1038/s42255-023-00916-6 |
0.564 |
|
| 2023 |
Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, Stockwell B, Kroemer G, Kang R, Tang D. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Science Translational Medicine. 15: eadg3049. PMID 37910602 DOI: 10.1126/scitranslmed.adg3049 |
0.314 |
|
| 2023 |
Mondesir J, Ghisi M, Poillet L, Bossong RA, Kepp O, Kroemer G, Sarry JE, Tamburini J, Lane AA. AMPK activation induces immunogenic cell death in AML. Blood Advances. PMID 37903311 DOI: 10.1182/bloodadvances.2022009444 |
0.338 |
|
| 2023 |
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L. Immunosurveillance in clinical cancer management. Ca: a Cancer Journal For Clinicians. PMID 37880100 DOI: 10.3322/caac.21818 |
0.478 |
|
| 2023 |
Kepp O, Liu P, Kroemer G, Galluzzi L. A mitochondrial checkpoint to adaptive anticancer immunity. Oncoimmunology. 12: 2271693. PMID 37860277 DOI: 10.1080/2162402X.2023.2271693 |
0.512 |
|
| 2023 |
Liu P, Zhao L, Zitvogel L, Kepp O, Kroemer G. The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation. Cell Death and Differentiation. PMID 37845384 DOI: 10.1038/s41418-023-01232-y |
0.416 |
|
| 2023 |
Zhao L, Liu P, Mao M, Zhang S, Bigenwald C, Dutertre CA, Lehmann CHK, Pan H, Paulhan N, Amon L, Buque A, Yamazaki T, Galluzzi L, Kloeckner B, Silvin A, ... ... Kroemer G, et al. BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer Discovery. PMID 37623817 DOI: 10.1158/2159-8290.CD-22-1338 |
0.477 |
|
| 2023 |
Le Naour J, Montégut L, Pan Y, Scuderi SA, Cordier P, Joseph A, Sauvat A, Iebba V, Paillet J, Ferrere G, Brechard L, Mulot C, Dubourg G, Zitvogel L, Pol JG, ... ... Kroemer G, et al. Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis. Oncoimmunology. 12: 2237354. PMID 37492227 DOI: 10.1080/2162402X.2023.2237354 |
0.601 |
|
| 2023 |
Sprooten J, Laureano RS, Vanmeerbeek I, Govaerts J, Naulaerts S, Borras DM, Kinget L, Fucíková J, Špíšek R, Jelínková LP, Kepp O, Kroemer G, Krysko DV, Coosemans A, Vaes RDW, et al. Trial watch: chemotherapy-induced immunogenic cell death in oncology. Oncoimmunology. 12: 2219591. PMID 37284695 DOI: 10.1080/2162402X.2023.2219591 |
0.371 |
|
| 2023 |
Guilbaud E, Kroemer G, Galluzzi L. Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell. 41: 1014-1016. PMID 37207656 DOI: 10.1016/j.ccell.2023.04.015 |
0.414 |
|
| 2023 |
Källberg J, Harrison A, March V, Bērziņa S, Nemazanyy I, Kepp O, Kroemer G, Mouillet-Richard S, Laurent-Puig P, Taly V, Xiao W. Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer. Cell Death & Disease. 14: 306. PMID 37142595 DOI: 10.1038/s41419-023-05806-z |
0.31 |
|
| 2023 |
Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, ... ... Kroemer G, et al. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death and Differentiation. PMID 37100955 DOI: 10.1038/s41418-023-01153-w |
0.733 |
|
| 2023 |
Barriuso D, Alvarez-Frutos L, Gonzalez-Gutierrez L, Motiño O, Kroemer G, Palacios-Ramirez R, Senovilla L. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence. International Journal of Molecular Sciences. 24. PMID 37047342 DOI: 10.3390/ijms24076374 |
0.334 |
|
| 2023 |
Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA Damage Response and Inflammation in Cancer. Cancer Discovery. OF1-OF25. PMID 37026695 DOI: 10.1158/2159-8290.CD-22-1220 |
0.472 |
|
| 2023 |
Zhang J, Trojel-Hansen C, Wang J, Zhang Z, Wang X, Qiao Y, Jiao H, Michaud M, Kepp O, Jäättelä M, Kroemer G, Zhong Q. Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells. Cell Death & Disease. 14: 238. PMID 37015922 DOI: 10.1038/s41419-023-05740-0 |
0.442 |
|
| 2023 |
Carbonnier V, Le Naour J, Bachelot T, Vacchelli E, André F, Delaloge S, Kroemer G. Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer. Oncoimmunology. 12: 2189823. PMID 36970071 DOI: 10.1080/2162402X.2023.2189823 |
0.557 |
|
| 2023 |
Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. Journal of Translational Medicine. 21: 162. PMID 36864446 DOI: 10.1186/s12967-023-04017-6 |
0.543 |
|
| 2023 |
Kepp O, Pan H, Liu P, Kroemer G. Arsenic trioxide as an inducer of immunogenic cell death. Oncoimmunology. 12: 2174723. PMID 36776523 DOI: 10.1080/2162402X.2023.2174723 |
0.346 |
|
| 2023 |
Giannoula Y, Kroemer G, Pietrocola F. Cellular senescence and the host immune system in aging and age-related disorders. Biomedical Journal. PMID 36746349 DOI: 10.1016/j.bj.2023.02.001 |
0.625 |
|
| 2023 |
Castedo M, Lafarge A, Kroemer G. Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death. Cell Stress. 7: 1-6. PMID 36743979 DOI: 10.15698/cst2023.01.275 |
0.336 |
|
| 2023 |
Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, Kroemer G, Chen X, Tang D, Liu J. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 1-15. PMID 36622894 DOI: 10.1080/15548627.2023.2165323 |
0.303 |
|
| 2023 |
López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metabolism. 35: 12-35. PMID 36599298 DOI: 10.1016/j.cmet.2022.11.001 |
0.65 |
|
| 2022 |
Castoldi F, Kroemer G, Pietrocola F. Spermidine rejuvenates T lymphocytes and restores anticancer immunosurveillance in aged mice. Oncoimmunology. 11: 2146855. PMID 36387057 DOI: 10.1080/2162402X.2022.2146855 |
0.578 |
|
| 2022 |
Galluzzi L, Kroemer G. Calreticulin surface presentation can promote quality control of hematopoietic stem cells. Trends in Immunology. PMID 36307308 DOI: 10.1016/j.it.2022.10.008 |
0.429 |
|
| 2022 |
Pol JG, Plantureux C, Pérez-Lanzón M, Kroemer G. PDIA3 as a potential bridge between immunogenic cell death and autoreactivity. Oncoimmunology. 11: 2130558. PMID 36211809 DOI: 10.1080/2162402X.2022.2130558 |
0.301 |
|
| 2022 |
Motiño O, Lambertucci F, Anagnostopoulos G, Li S, Nah J, Castoldi F, Senovilla L, Montégut L, Chen H, Durand S, Bourgin M, Aprahamian F, Nirmalathasan N, Alvarez-Valadez K, Sauvat A, ... ... Kroemer G, et al. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 119: e2207344119. PMID 36191214 DOI: 10.1073/pnas.2207344119 |
0.595 |
|
| 2022 |
Zhao L, Zhang S, Chen H, Kroemer G, Kepp O, Liu P. Interference of immunogenic chemotherapy by artificially controlled calreticulin secretion from tumor cells. Methods in Cell Biology. 172: 99-114. PMID 36064229 DOI: 10.1016/bs.mcb.2021.12.027 |
0.361 |
|
| 2022 |
Galluzzi L, Kroemer G. Immuno-epigenetic escape of cancer stem cells. Nature Immunology. 23: 1300-1302. PMID 36002649 DOI: 10.1038/s41590-022-01293-0 |
0.408 |
|
| 2022 |
Ichim G, Gibert B, Adriouch S, Brenner C, Davoust N, Desagher S, Devos D, Dokudovskaya S, Dubrez L, Estaquier J, Gillet G, Guénal I, Juin PP, Kroemer G, Legembre P, et al. Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network. Biomolecules. 12. PMID 35883457 DOI: 10.3390/biom12070901 |
0.341 |
|
| 2022 |
Juncheng P, Joseph A, Lafarge A, Martins I, Obrist F, Pol J, Saavedra E, Li S, Sauvat A, Cerrato G, Lévesque S, Leduc M, Kepp O, Durand S, Aprahamian F, ... ... Kroemer G, et al. Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer. Journal For Immunotherapy of Cancer. 10. PMID 35772809 DOI: 10.1136/jitc-2021-004280 |
0.683 |
|
| 2022 |
Kepp O, Bezu L, Kroemer G. The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers? Oncoimmunology. 11: 2092328. PMID 35756845 DOI: 10.1080/2162402X.2022.2092328 |
0.333 |
|
| 2022 |
Anagnostopoulos G, Motiño O, Li S, Carbonnier V, Chen H, Sica V, Durand S, Bourgin M, Aprahamian F, Nirmalathasan N, Donne R, Desdouets C, Sola MS, Kotta K, Montégut L, ... ... Kroemer G, et al. Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor. Cell Death & Disease. 13: 430. PMID 35504865 DOI: 10.1038/s41419-022-04884-9 |
0.481 |
|
| 2022 |
Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology. 11: 2059878. PMID 35481288 DOI: 10.1080/2162402X.2022.2059878 |
0.682 |
|
| 2022 |
Anagnostopoulos G, Motiño O, Li S, Carbonnier V, Chen H, Sica V, Durand S, Bourgin M, Aprahamian F, Nirmalathasan N, Donne R, Desdouets C, Sola MS, Kotta K, Montégut L, ... ... Kroemer G, et al. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor. Cell Death & Disease. 13: 356. PMID 35436993 DOI: 10.1038/s41419-022-04834-5 |
0.538 |
|
| 2022 |
Del Giudice R, Imbimbo P, Pietrocola F, Martins I, De Palma FDE, Bravo-San Pedro JM, Kroemer G, Maiuri MC, Monti DM. Autophagy Alteration in ApoA-I Related Systemic Amyloidosis. International Journal of Molecular Sciences. 23. PMID 35408859 DOI: 10.3390/ijms23073498 |
0.659 |
|
| 2022 |
Chen X, Song X, Li J, Zhang R, Yu C, Zhou Z, Liu J, Liao S, Klionsky DJ, Kroemer G, Liu J, Tang D, Kang R. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy. 1-21. PMID 35403545 DOI: 10.1080/15548627.2022.2059170 |
0.304 |
|
| 2022 |
Kennedy BE, Giacomantonio M, Murphy JP, Cutler S, Sadek M, Konda P, Paulo JA, Pathak GP, Renkens SHJ, Grieve S, Pol J, Gygi SP, Richardson C, Gaston D, Reiman A, ... Kroemer G, et al. NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma. Molecular Therapy Oncolytics. 24: 695-706. PMID 35284625 DOI: 10.1016/j.omto.2022.02.017 |
0.349 |
|
| 2022 |
Le Naour J, Montégut L, Joseph A, Garbin K, Vacchelli E, Kroemer G, Pol JG, Maiuri MC. Improved Swiss-rolling method for histological analyses of colon tissue. Methodsx. 9: 101630. PMID 35242614 DOI: 10.1016/j.mex.2022.101630 |
0.53 |
|
| 2022 |
Sommer A, Berndt S, Lerchen HG, Forveille S, Sauvat A, Mumberg D, Kroemer G, Kepp O. Antibody-drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties. Oncoimmunology. 11: 2037216. PMID 35154909 DOI: 10.1080/2162402X.2022.2037216 |
0.315 |
|
| 2022 |
Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nature Immunology. PMID 35145297 DOI: 10.1038/s41590-022-01132-2 |
0.521 |
|
| 2021 |
Airiau K, Vacher P, Micheau O, Prouzet-Mauleon V, Kroemer G, Moosavi MA, Djavaheri-Mergny M. TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex. Cells. 11. PMID 35011619 DOI: 10.3390/cells11010057 |
0.393 |
|
| 2021 |
Deng J, Gutiérrez LG, Stoll G, Motiño O, Martins I, Núñez L, Bravo-San Pedro JM, Humeau J, Bordenave C, Pan J, Fohrer-Ting H, Souquere S, Pierron G, Hetz C, Villalobos C, ... Kroemer G, et al. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells. Cell Death & Disease. 12: 1039. PMID 34725331 DOI: 10.1038/s41419-021-04321-3 |
0.367 |
|
| 2021 |
Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology. 10: 1984677. PMID 34676147 DOI: 10.1080/2162402X.2021.1984677 |
0.501 |
|
| 2021 |
Zitvogel L, Kroemer G. Bortezomib Induces Immunogenic Cell Death in Multiple Myeloma. Blood Cancer Discovery. 2: 405-407. PMID 34661160 DOI: 10.1158/2643-3230.BCD-21-0059 |
0.394 |
|
| 2021 |
Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K, Cecconi F, Choi AMK, Choi ME, Chu CT, Codogno P, Colombo MI, Cuervo AM, ... ... Kroemer G, et al. Autophagy in major human diseases. The Embo Journal. e108863. PMID 34459017 DOI: 10.15252/embj.2021108863 |
0.673 |
|
| 2021 |
Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nature Reviews. Gastroenterology & Hepatology. PMID 34331036 DOI: 10.1038/s41575-021-00486-6 |
0.355 |
|
| 2021 |
Joseph A, Pan J, Michels J, Kroemer G, Castedo M. Pyridoxal kinase and poly(ADP-ribose) affect the immune microenvironment of locally advanced cancers. Oncoimmunology. 10: 1950954. PMID 34290910 DOI: 10.1080/2162402X.2021.1950954 |
0.671 |
|
| 2021 |
Petrazzuolo A, Perez-Lanzon M, Martins I, Liu P, Kepp O, Minard-Colin V, Maiuri MC, Kroemer G. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects. Cell Death & Disease. 12: 713. PMID 34272360 DOI: 10.1038/s41419-021-03997-x |
0.38 |
|
| 2021 |
Montes de Oca R, Alavi AS, Vitali N, Bhattacharya S, Blackwell C, Patel K, Seestaller-Wehr L, Kaczynski H, Shi H, Dobrzynski E, Obert L, Tsvetkov L, Cooper DC, Jackson H, Bojczuk P, ... ... Kroemer G, et al. Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-Mediated Anti-Tumor Responses In Vivo. Molecular Cancer Therapeutics. PMID 34253590 DOI: 10.1158/1535-7163.MCT-21-0035 |
0.31 |
|
| 2021 |
Joseph A, Juncheng P, Mondini M, Labaied N, Loi M, Adam J, Lafarge A, Astesana V, Obrist F, Klein C, Bloy N, Stoll G, Signolle N, Genestie C, Damotte D, ... ... Kroemer G, et al. Metabolic features of cancer cells impact immunosurveillance. Journal For Immunotherapy of Cancer. 9. PMID 34162714 DOI: 10.1136/jitc-2021-002362 |
0.674 |
|
| 2021 |
Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L. ATP and cancer immunosurveillance. The Embo Journal. e108130. PMID 34121201 DOI: 10.15252/embj.2021108130 |
0.454 |
|
| 2021 |
Wu Q, Tian AL, Kroemer G, Kepp O. Autophagy induction by IGF1R inhibition with picropodophyllin and linsitinib. Autophagy. 1-2. PMID 34110249 DOI: 10.1080/15548627.2021.1936934 |
0.344 |
|
| 2021 |
Cano CE, José Sandí M, Hamidi T, Calvo EL, Turrini O, Bartholin L, Loncle C, Secq V, Garcia S, Lomberk G, Kroemer G, Urrutia R, Iovanna JL. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. Embo Molecular Medicine. 13: e14243. PMID 33960146 DOI: 10.15252/emmm.202114243 |
0.312 |
|
| 2021 |
Bravo-San Pedro JM, Kepp O, Sauvat A, Rello-Varona S, Kroemer G, Senovilla L. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe. Methods in Molecular Biology (Clifton, N.J.). 2267: 227-239. PMID 33786796 DOI: 10.1007/978-1-0716-1217-0_16 |
0.343 |
|
| 2021 |
Bezu L, Kepp O, Kroemer G. Calreticulin Exposure in Mitotic Catastrophe. Methods in Molecular Biology (Clifton, N.J.). 2267: 207-215. PMID 33786794 DOI: 10.1007/978-1-0716-1217-0_14 |
0.366 |
|
| 2021 |
Buqué A, Perez-Lanzón M, Petroni G, Humeau J, Bloy N, Yamazaki T, Sato A, Kroemer G, Galluzzi L. MPA/DMBA-driven mammary carcinomas. Methods in Cell Biology. 163: 1-19. PMID 33785159 DOI: 10.1016/bs.mcb.2020.08.003 |
0.366 |
|
| 2021 |
Workenhe ST, Pol J, Kroemer G. Tumor-intrinsic determinants of immunogenic cell death modalities. Oncoimmunology. 10: 1893466. PMID 33717656 DOI: 10.1080/2162402X.2021.1893466 |
0.318 |
|
| 2021 |
Sevin M, Debeurme F, Laplane L, Badel S, Morabito M, Newman HL, Torres-Martin M, Yang Q, Badaoui B, Wagner-Ballon O, Saada V, Selimoglu-Buet D, Kraus-Berthier L, Banquet S, Derreal A, ... ... Kroemer G, et al. Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML. Blood. PMID 33690800 DOI: 10.1182/blood.2020008729 |
0.588 |
|
| 2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Kroemer G, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.804 |
|
| 2021 |
Buqué A, Galluzzi L, Kroemer G. Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy. Molecular & Cellular Oncology. 8: 1868266. PMID 33553614 DOI: 10.1080/23723556.2020.1868266 |
0.381 |
|
| 2021 |
Petroni G, Kroemer G, Galluzzi L. Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends in Cancer. PMID 33518493 DOI: 10.1016/j.trecan.2021.01.005 |
0.435 |
|
| 2021 |
Sztupinszki Z, Le Naour J, Vacchelli E, Laurent-Puig P, Delaloge S, Szallasi Z, Kroemer G. A major genetic accelerator of cancer diagnosis: rs867228 in FPR1. Oncoimmunology. 10: 1859064. PMID 33489470 DOI: 10.1080/2162402X.2020.1859064 |
0.549 |
|
| 2020 |
Tang D, Kepp O, Kroemer G. Ferroptosis becomes immunogenic: implications for anticancer treatments. Oncoimmunology. 10: 1862949. PMID 33457081 DOI: 10.1080/2162402X.2020.1862949 |
0.321 |
|
| 2020 |
Petrazzuolo A, Le Naour J, Vacchelli E, Gaussem P, Ellouze S, Jourdi G, Solary E, Fontenay M, Smadja DM, Kroemer G. No impact of cancer and plague-relevant polymorphisms on COVID-19. Oncoimmunology. 9: 1857112. PMID 33344044 DOI: 10.1080/2162402X.2020.1857112 |
0.563 |
|
| 2020 |
Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell. PMID 33338426 DOI: 10.1016/j.ccell.2020.11.009 |
0.405 |
|
| 2020 |
Yamazaki T, Pedro JMB, Galluzzi L, Kroemer G, Pietrocola F. Autophagy in the cancer-immunity dialogue. Advanced Drug Delivery Reviews. PMID 33301821 DOI: 10.1016/j.addr.2020.12.003 |
0.728 |
|
| 2020 |
Castoldi F, Humeau J, Martins I, Lachkar S, Loew D, Dingli F, Durand S, Enot D, Bossut N, Chery A, Aprahamian F, Demont Y, Opolon P, Signolle N, Sauvat A, ... ... Kroemer G, et al. Autophagy-mediated metabolic effects of aspirin. Cell Death Discovery. 6: 129. PMID 33298861 DOI: 10.1038/s41420-020-00365-0 |
0.817 |
|
| 2020 |
Checcoli A, Pol JG, Naldi A, Noel V, Barillot E, Kroemer G, Thieffry D, Calzone L, Stoll G. Dynamical Boolean Modeling of Immunogenic Cell Death. Frontiers in Physiology. 11: 590479. PMID 33281620 DOI: 10.3389/fphys.2020.590479 |
0.35 |
|
| 2020 |
Wu Q, Tian AL, Durand S, Aprahamian F, Nirmalathasan N, Xie W, Liu P, Zhao L, Zhang S, Pan H, Carmona-Gutierrez D, Madeo F, Tu Y, Kepp O, Kroemer G. Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy. Cell Death & Disease. 11: 1015. PMID 33243998 DOI: 10.1038/s41419-020-03226-x |
0.374 |
|
| 2020 |
Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease. 11: 1013. PMID 33243969 DOI: 10.1038/s41419-020-03221-2 |
0.547 |
|
| 2020 |
Le Naour J, Liu P, Zhao L, Adjemian S, Sztupinszki Z, Taieb J, Mulot C, Silvin A, Dutertre CA, Ginhoux F, Sauvat A, Cerrato G, Castoldi F, Martins I, Stoll G, ... ... Kroemer G, et al. A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency. Cancer Discovery. PMID 33046534 DOI: 10.1158/2159-8290.CD-20-0465 |
0.801 |
|
| 2020 |
Humeau J, Bezu L, Kepp O, Kroemer G. EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell death. Molecular & Cellular Oncology. 7: 1776570. PMID 32944635 DOI: 10.1080/23723556.2020.1776570 |
0.42 |
|
| 2020 |
Sica V, Kroemer G. A bidirectional crosstalk between autophagy and TP53 determines the pace of aging. Molecular & Cellular Oncology. 7: 1769434. PMID 32944630 DOI: 10.1080/23723556.2020.1769434 |
0.603 |
|
| 2020 |
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Kroemer G, et al. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 4787. PMID 32943636 DOI: 10.1038/S41467-020-18719-8 |
0.426 |
|
| 2020 |
Song X, Zhou Z, Li H, Xue Y, Lu X, Bahar I, Kepp O, Hung MC, Kroemer G, Wan Y. Pharmacological suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers. Cancer Discovery. PMID 32938586 DOI: 10.1158/2159-8290.Cd-20-0402 |
0.359 |
|
| 2020 |
Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O. Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology. 9: 1796002. PMID 32934889 DOI: 10.1080/2162402X.2020.1796002 |
0.695 |
|
| 2020 |
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 9: 1777625. PMID 32934882 DOI: 10.1080/2162402X.2020.1777625 |
0.7 |
|
| 2020 |
Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G. Trial watch: STING agonists in cancer therapy. Oncoimmunology. 9: 1777624. PMID 32934881 DOI: 10.1080/2162402X.2020.1777624 |
0.696 |
|
| 2020 |
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology. 9: 1771143. PMID 32934877 DOI: 10.1080/2162402X.2020.1771143 |
0.666 |
|
| 2020 |
Buque A, Bloy N, Petroni G, Kroemer G, Galluzzi L. NK cells beat T cells at early breast cancer control. Oncoimmunology. 9: 1806010. PMID 32923169 DOI: 10.1080/2162402X.2020.1806010 |
0.513 |
|
| 2020 |
Kepp O, Zitvogel L, Kroemer G. Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer. Oncoimmunology. 9: 1795995. PMID 32923159 DOI: 10.1080/2162402X.2020.1795995 |
0.319 |
|
| 2020 |
Kepp O, Liu P, Zhao L, Plo I, Kroemer G. Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis. Oncoimmunology. 9: 1792037. PMID 32923154 DOI: 10.1080/2162402X.2020.1792037 |
0.325 |
|
| 2020 |
Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, ... ... Kroemer G, et al. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science (New York, N.Y.). 369: 936-942. PMID 32820119 DOI: 10.1126/Science.Aax0701 |
0.311 |
|
| 2020 |
Sauvat A, Ciccosanti F, Colavita F, Di Rienzo M, Castilletti C, Capobianchi MR, Kepp O, Zitvogel L, Fimia GM, Piacentini M, Kroemer G. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death & Disease. 11: 656. PMID 32814759 DOI: 10.1038/S41419-020-02842-X |
0.306 |
|
| 2020 |
Pol JG, Atherton MJ, Stephenson KB, Bridle BW, Workenhe ST, Kazdhan N, McGray AR, Wan Y, Kroemer G, Lichty BD. Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal For Immunotherapy of Cancer. 8. PMID 32792361 DOI: 10.1136/Jitc-2020-000981 |
0.331 |
|
| 2020 |
Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology. PMID 32760014 DOI: 10.1038/S41571-020-0413-Z |
0.546 |
|
| 2020 |
Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Research. PMID 32733014 DOI: 10.1038/S41422-020-0383-9 |
0.568 |
|
| 2020 |
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Kroemer G, et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 3819. PMID 32732875 DOI: 10.1038/S41467-020-17644-0 |
0.504 |
|
| 2020 |
Pietrocola F, Castoldi F, Zischka H, Kroemer G. Extending the mode of action of triethylenetetramine (trientine): Autophagy besides copper chelation. Journal of Hepatology. PMID 32684364 DOI: 10.1016/J.Jhep.2020.05.046 |
0.59 |
|
| 2020 |
Joseph A, Moriceau S, Sica V, Anagnostopoulos G, Pol J, Martins I, Lafarge A, Maiuri MC, Leboyer M, Loftus J, Bellivier F, Belzeaux R, Berna F, Etain B, Capdevielle D, ... ... Kroemer G, et al. Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI). Cell Death & Disease. 11: 502. PMID 32632162 DOI: 10.1038/S41419-020-2716-5 |
0.573 |
|
| 2020 |
Beauvarlet J, Nath Das R, Alvarez-Valadez K, Martins I, Muller A, Darbo E, Richard E, Soubeyran P, Kroemer G, Guillon J, Mergny JL, Djavaheri-Mergny M. Triarylpyridine Compounds and Chloroquine Act in Concert to Trigger Lysosomal Membrane Permeabilization and Cell Death in Cancer Cells. Cancers. 12. PMID 32570977 DOI: 10.3390/Cancers12061621 |
0.429 |
|
| 2020 |
Pietrocola F, Castoldi F, Madeo F, Kroemer G. Triethylenetetramine (trientine): a caloric restriction mimetic with a new mode of action. Autophagy. 1-3. PMID 32544364 DOI: 10.1080/15548627.2020.1778293 |
0.656 |
|
| 2020 |
Humeau J, Leduc M, Cerrato G, Loos F, Kepp O, Kroemer G. Phosphorylation of eukaryotic initiation factor-2α (eIF2α) in autophagy. Cell Death & Disease. 11: 433. PMID 32513922 DOI: 10.1038/S41419-020-2642-6 |
0.369 |
|
| 2020 |
Kroemer G, Zitvogel L. Seeking Cellular Fitness and Immune Evasion: Autophagy in Pancreatic Carcinoma. Cancer Cell. 37: 759-760. PMID 32470391 DOI: 10.1016/J.Ccell.2020.05.009 |
0.345 |
|
| 2020 |
Roberti MP, Yonekura S, Duong CPM, Picard M, Ferrere G, Tidjani Alou M, Rauber C, Iebba V, Lehmann CHK, Amon L, Dudziak D, Derosa L, Routy B, Flament C, Richard C, ... ... Kroemer G, et al. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nature Medicine. PMID 32451498 DOI: 10.1038/S41591-020-0882-8 |
0.325 |
|
| 2020 |
Dufey E, Bravo-San Pedro JM, Eggers C, González-Quiroz M, Urra H, Sagredo AI, Sepulveda D, Pihán P, Carreras-Sureda A, Hazari Y, Sagredo EA, Gutierrez D, Valls C, Papaioannou A, Acosta-Alvear D, ... ... Kroemer G, et al. Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response. Nature Communications. 11: 2401. PMID 32409639 DOI: 10.1038/S41467-020-15694-Y |
0.354 |
|
| 2020 |
Kroemer G, Zitvogel L. CD4 T Cells at the Center of Inflammaging. Cell Metabolism. 32: 4-5. PMID 32402265 DOI: 10.1016/J.Cmet.2020.04.016 |
0.307 |
|
| 2020 |
Carmona-Gutierrez D, Bauer MA, Zimmermann A, Kainz K, Hofer SJ, Kroemer G, Madeo F. Digesting the crisis: autophagy and coronaviruses. Microbial Cell (Graz, Austria). 7: 119-128. PMID 32391393 DOI: 10.15698/Mic2020.05.715 |
0.38 |
|
| 2020 |
Vacchelli E, Le Naour J, Kroemer G. The ambiguous role of FPR1 in immunity and inflammation. Oncoimmunology. 9: 1760061. PMID 32391192 DOI: 10.1080/2162402X.2020.1760061 |
0.549 |
|
| 2020 |
Buqué A, Bloy N, Kroemer G, Galluzzi L. Potential mechanisms of cancer prevention by nicotinamide. British Journal of Pharmacology. PMID 32383227 DOI: 10.1111/Bph.15096 |
0.471 |
|
| 2020 |
Castoldi F, Hyvönen MT, Durand S, Aprahamian F, Sauvat A, Malik SA, Baracco EE, Vacchelli E, Opolon P, Signolle N, Lefevre D, Bossut N, Eisenberg T, Dammbrueck C, Pendl T, ... ... Kroemer G, et al. Chemical activation of SAT1 corrects diet-induced metabolic syndrome. Cell Death and Differentiation. PMID 32376874 DOI: 10.1038/S41418-020-0550-Z |
0.781 |
|
| 2020 |
Huang Y, Wang H, Hao Y, Lin H, Dong M, Ye J, Song L, Wang Y, Li Q, Shan B, Jiang Y, Li H, Shao Z, Kroemer G, Zhang H, et al. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nature Cell Biology. PMID 32367047 DOI: 10.1038/S41556-020-0510-3 |
0.394 |
|
| 2020 |
Pol JG, Le Naour J, Kroemer G. FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin. Oncoimmunology. 9: 1755214. PMID 32363127 DOI: 10.1080/2162402X.2020.1755214 |
0.42 |
|
| 2020 |
Kepp O, Kroemer G. Autophagy induction by thiostrepton for the improvement of anticancer therapy. Autophagy. 16: 1166-1167. PMID 32330398 DOI: 10.1080/15548627.2020.1758417 |
0.454 |
|
| 2020 |
Ravel JM, Monraz Gomez LC, Sompairac N, Calzone L, Zhivotovsky B, Kroemer G, Barillot E, Zinovyev A, Kuperstein I. Comprehensive Map of the Regulated Cell Death Signaling Network: A Powerful Analytical Tool for Studying Diseases. Cancers. 12. PMID 32316560 DOI: 10.3390/Cancers12040990 |
0.344 |
|
| 2020 |
Chong SJF, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S. Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology. PMID 32307222 DOI: 10.1016/J.Tcb.2020.03.004 |
0.603 |
|
| 2020 |
Galluzzi L, Kroemer G. Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends in Cell Biology. 30: 339-340. PMID 32302546 DOI: 10.1016/J.Tcb.2020.02.004 |
0.549 |
|
| 2020 |
Chen G, Kroemer G, Kepp O. Mitophagy: An Emerging Role in Aging and Age-Associated Diseases. Frontiers in Cell and Developmental Biology. 8: 200. PMID 32274386 DOI: 10.3389/Fcell.2020.00200 |
0.327 |
|
| 2020 |
Galluzzi L, Petroni G, Kroemer G. Immunogenicity of cell death driven by immune effectors. Journal For Immunotherapy of Cancer. 8. PMID 32253221 DOI: 10.1136/Jitc-2020-000802 |
0.563 |
|
| 2020 |
Kroemer G, Pietrocola F. The scent of death: a metabolic goodbye signal emitted by dying cells. Cell Death and Differentiation. PMID 32251367 DOI: 10.1038/S41418-020-0533-0 |
0.656 |
|
| 2020 |
Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. Journal For Immunotherapy of Cancer. 8. PMID 32221018 DOI: 10.1136/Jitc-2019-000462 |
0.413 |
|
| 2020 |
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, ... ... Kroemer G, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32209603 DOI: 10.1136/Jitc-2019-000337 |
0.779 |
|
| 2020 |
Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-Dependent Ferroptosis: Machinery and Regulation. Cell Chemical Biology. PMID 32160513 DOI: 10.1016/J.Chembiol.2020.02.005 |
0.428 |
|
| 2020 |
Sica V, Martins I, Motiño O, Bravo-San Pedro JM, Kroemer G. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects. Adipocyte. 9: 116-119. PMID 32157940 DOI: 10.1080/21623945.2020.1736734 |
0.521 |
|
| 2020 |
Kepp O, Kroemer G. A novel platinum-based chemotherapeutic inducing immunogenic cell death. Oncoimmunology. 9: 1729022. PMID 32117595 DOI: 10.1080/2162402X.2020.1729022 |
0.472 |
|
| 2020 |
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology. 9: 1703449. PMID 32002302 DOI: 10.1080/2162402X.2019.1703449 |
0.581 |
|
| 2020 |
Hamy AS, Derosa L, Valdelièvre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, Pinheiro A, Lae M, Talagrand LS, Laas E, Darrigues L, ... ... Kroemer G, et al. Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. Oncoimmunology. 9: 1677427. PMID 32002287 DOI: 10.1080/2162402X.2019.1677427 |
0.301 |
|
| 2020 |
Ma Y, Yang H, Kroemer G. Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies. Oncoimmunology. 9: 1673635. PMID 32002285 DOI: 10.1080/2162402X.2019.1673635 |
0.348 |
|
| 2020 |
Li T, Li K, Zhang S, Wang Y, Xu Y, Cronin SJF, Sun Y, Zhang Y, Xie C, Rodriguez J, Zhou K, Hagberg H, Mallard C, Wang X, Penninger JM, ... Kroemer G, et al. Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice. Cell Death & Disease. 11: 77. PMID 32001673 DOI: 10.1038/S41419-020-2280-Z |
0.315 |
|
| 2020 |
Cerrato G, Liu P, Martins I, Kepp O, Kroemer G. Quantitative determination of phagocytosis by bone marrow-derived dendritic cells via imaging flow cytometry. Methods in Enzymology. 632: 27-37. PMID 32000900 DOI: 10.1016/Bs.Mie.2019.07.021 |
0.413 |
|
| 2020 |
Kasikova L, Truxova I, Cremer I, Sautes-Fridman C, Kepp O, Kroemer G, Spisek R, Fucikova J. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death. Methods in Enzymology. 632: 15-25. PMID 32000894 DOI: 10.1016/Bs.Mie.2019.05.025 |
0.411 |
|
| 2020 |
Liu P, Zhao L, Kepp O, Kroemer G. Quantitation of calreticulin exposure associated with immunogenic cell death. Methods in Enzymology. 632: 1-13. PMID 32000891 DOI: 10.1016/Bs.Mie.2019.05.011 |
0.427 |
|
| 2020 |
Charmpilas N, Ruckenstuhl C, Sica V, Büttner S, Habernig L, Dichtinger S, Madeo F, Tavernarakis N, Bravo-San Pedro JM, Kroemer G. Acyl-CoA-binding protein (ACBP): a phylogenetically conserved appetite stimulator. Cell Death & Disease. 11: 7. PMID 31907349 DOI: 10.1038/S41419-019-2205-X |
0.573 |
|
| 2020 |
Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. Journal of Hepatology. 72: 183-196. PMID 31849347 DOI: 10.1016/J.Jhep.2019.08.026 |
0.511 |
|
| 2020 |
Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Annals of Oncology : Official Journal of the European Society For Medical Oncology. 30: 1572-1579. PMID 31268133 DOI: 10.1093/Annonc/Mdz206 |
0.302 |
|
| 2020 |
Zitvogel L, Kroemer G. Interferon-γ induces cancer cell ferroptosis. Cell Research. 29: 692-693. PMID 31160718 DOI: 10.1038/S41422-019-0186-Z |
0.4 |
|
| 2020 |
Abdellatif M, Sedej S, Madeo F, Kroemer G. Cardioprotective effects of autophagy induction in sepsis. Annals of Translational Medicine. 6: S61. PMID 30613636 DOI: 10.21037/Atm.2018.10.23 |
0.38 |
|
| 2020 |
Joseph A, Castedo-Delrieu M, Bloy N, Labaied N, Mondini M, Loi M, Klein C, Genestie C, Pautier P, Morice P, Gouy S, Deutsch E, Chargary C, Kroemer G, Michels J. Prognostic value of dendritic cells in locally advanced cervical cancer patients. Journal of Clinical Oncology. 38: e18016-e18016. DOI: 10.1200/Jco.2020.38.15_Suppl.E18016 |
0.681 |
|
| 2020 |
Comes MC, Filippi J, Mencattini A, Casti P, Cerrato G, Sauvat A, Vacchelli E, Ninno AD, Giuseppe DD, D’Orazio M, Mattei F, Schiavoni G, Businaro L, Natale CD, Kroemer G, et al. Multi-scale generative adversarial network for improved evaluation of cell–cell interactions observed in organ-on-chip experiments Neural Computing and Applications. 1-19. DOI: 10.1007/S00521-020-05226-6 |
0.603 |
|
| 2019 |
Baracco EE, Stoll G, Van Endert P, Zitvogel L, Vacchelli E, Kroemer G. Contribution of annexin A1 to anticancer immunosurveillance. Oncoimmunology. 8: e1647760. PMID 32923172 DOI: 10.1080/2162402X.2019.1647760 |
0.659 |
|
| 2019 |
Wu Chuang A, Kepp O, Kroemer G, Bezu L. Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns. International Review of Cell and Molecular Biology. 350: 1-28. PMID 32138898 DOI: 10.1016/Bs.Ircmb.2019.11.006 |
0.398 |
|
| 2019 |
Bezu L, Chuang AW, Liu P, Kroemer G, Kepp O. Immunological Effects of Epigenetic Modifiers. Cancers. 11. PMID 31805711 DOI: 10.3390/Cancers11121911 |
0.308 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Kroemer G, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. 30: 1171. PMID 31801056 DOI: 10.1016/j.cmet.2019.10.011 |
0.576 |
|
| 2019 |
Liu P, Zhao L, Loos F, Marty C, Xie W, Martins I, Lachkar S, Qu B, Waeckel-Énée E, Plo I, Vainchenker W, Perez F, Rodriguez D, López-Otin C, van Endert P, ... ... Kroemer G, et al. Immunosuppression by Mutated Calreticulin Released from Malignant Cells. Molecular Cell. PMID 31785928 DOI: 10.1016/J.Molcel.2019.11.004 |
0.373 |
|
| 2019 |
Gehrmann U, Burbage M, Zueva E, Goudot C, Esnault C, Ye M, Carpier JM, Burgdorf N, Hoyler T, Suarez G, Joannas L, Heurtebise-Chrétien S, Durand S, Panes R, Bellemare-Pelletier A, ... ... Kroemer G, et al. Critical role for TRIM28 and HP1β/γ in the epigenetic control of T cell metabolic reprograming and effector differentiation. Proceedings of the National Academy of Sciences of the United States of America. PMID 31776254 DOI: 10.1073/Pnas.1901639116 |
0.33 |
|
| 2019 |
Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, Praznovec I, Vosahlikova S, Halaska MJ, Brtnicky T, Rob L, Presl J, Kostun J, Cremer I, Ryska A, ... Kroemer G, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 7: 312. PMID 31747968 DOI: 10.1186/S40425-019-0781-Z |
0.518 |
|
| 2019 |
Baracco EE, Petrazzuolo A, Kroemer G. Assessment of annexin A1 release during immunogenic cell death. Methods in Enzymology. 629: 71-79. PMID 31727257 DOI: 10.1016/Bs.Mie.2019.06.010 |
0.417 |
|
| 2019 |
Bezu L, Wu Chuang A, Humeau J, Kroemer G, Kepp O. Quantification of eIF2alpha phosphorylation during immunogenic cell death. Methods in Enzymology. 629: 53-69. PMID 31727256 DOI: 10.1016/Bs.Mie.2019.04.010 |
0.468 |
|
| 2019 |
Zhao L, Liu P, Kepp O, Kroemer G. Methods for measuring HMGB1 release during immunogenic cell death. Methods in Enzymology. 629: 177-193. PMID 31727240 DOI: 10.1016/Bs.Mie.2019.05.001 |
0.397 |
|
| 2019 |
Forveille S, Humeau J, Sauvat A, Bezu L, Kroemer G, Kepp O. Quinacrine-mediated detection of intracellular ATP. Methods in Enzymology. 629: 103-113. PMID 31727236 DOI: 10.1016/Bs.Mie.2019.05.050 |
0.387 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Kroemer G. The elusive "hunger protein": an appetite-stimulatory factor that is overabundant in human obesity. Molecular & Cellular Oncology. 6: e1667193. PMID 31692883 DOI: 10.1080/23723556.2019.1667193 |
0.489 |
|
| 2019 |
Boncompain G, Gareil N, Tessier S, Lescure A, Jones TR, Kepp O, Kroemer G, Del Nery E, Perez F. BML-265 and Tyrphostin AG1478 Disperse the Golgi Apparatus and Abolish Protein Transport in Human Cells. Frontiers in Cell and Developmental Biology. 7: 232. PMID 31681765 DOI: 10.3389/Fcell.2019.00232 |
0.332 |
|
| 2019 |
Pedro JMB, Sica V, Madeo F, Kroemer G. Acyl-CoA-binding protein (ACBP): the elusive 'hunger factor' linking autophagy to food intake. Cell Stress. 3: 312-318. PMID 31656948 DOI: 10.15698/cst2019.10.200 |
0.515 |
|
| 2019 |
Lévesque S, Le Naour J, Pietrocola F, Paillet J, Kremer M, Castoldi F, Baracco EE, Wang Y, Vacchelli E, Stoll G, Jolly A, De La Grange P, Zitvogel L, Kroemer G, Pol JG. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. Oncoimmunology. 8: e1657375. PMID 31646107 DOI: 10.1080/2162402X.2019.1657375 |
0.751 |
|
| 2019 |
Xie W, Forveille S, Iribarren K, Sauvat A, Senovilla L, Wang Y, Humeau J, Perez-Lanzon M, Zhou H, Martínez-Leal JF, Kroemer G, Kepp O. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity. Oncoimmunology. 8: e1656502. PMID 31646106 DOI: 10.1080/2162402X.2019.1656502 |
0.402 |
|
| 2019 |
Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 8: e1638212. PMID 31646087 DOI: 10.1080/2162402X.2019.1638212 |
0.46 |
|
| 2019 |
Pietrocola F, Kroemer G. Caloric restriction promotes the stemness and antitumor activity of T lymphocytes. Oncoimmunology. 8: e1616153. PMID 31646069 DOI: 10.1080/2162402X.2019.1616153 |
0.656 |
|
| 2019 |
Chen G, Xie W, Nah J, Sauvat A, Liu P, Pietrocola F, Sica V, Carmona-Gutierrez D, Zimmermann A, Pendl T, Tadic J, Bergmann M, Hofer SJ, Domuz L, Lachkar S, ... ... Kroemer G, et al. 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB. Embo Molecular Medicine. e10469. PMID 31609086 DOI: 10.15252/Emmm.201910469 |
0.751 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Kroemer G. Pseudodiabetes-not a contraindication for metabolic interventions. Cell Death & Disease. 10: 765. PMID 31601789 DOI: 10.1038/S41419-019-2007-1 |
0.542 |
|
| 2019 |
Loos F, Xie W, Sica V, Bravo-San Pedro JM, Souquère S, Pierron G, Lachkar S, Sauvat A, Petrazzuolo A, Jimenez AJ, Perez F, Maiuri MC, Kepp O, Kroemer G. Artificial tethering of LC3 or p62 to organelles is not sufficient to trigger autophagy. Cell Death & Disease. 10: 771. PMID 31601788 DOI: 10.1038/S41419-019-2011-5 |
0.598 |
|
| 2019 |
Kepp O, Marabelle A, Zitvogel L, Kroemer G. Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies. Nature Reviews. Clinical Oncology. 17: 49-64. PMID 31595049 DOI: 10.1038/S41571-019-0272-7 |
0.311 |
|
| 2019 |
Kroemer G, Zitvogel L. Leptin-Producing Oncolytic Virus Makes Tumor-Infiltrating T Cells Fit, Not Fat. Immunity. 51: 423-425. PMID 31533054 DOI: 10.1016/J.Immuni.2019.08.010 |
0.307 |
|
| 2019 |
Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, Fu L, Yang J, Pan Z, Yu K, He J, ... ... Kroemer G, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nature Medicine. 25: 1428-1441. PMID 31501614 DOI: 10.1038/S41591-019-0566-4 |
0.376 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Martins I, Anagnostopoulos G, Maiuri C, Kroemer G. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. Autophagy. PMID 31470770 DOI: 10.1080/15548627.2019.1662585 |
0.602 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Kroemer G. A strategy for poisoning cancer cell metabolism: Inhibition of oxidative phosphorylation coupled to anaplerotic saturation. International Review of Cell and Molecular Biology. 347: 27-37. PMID 31451215 DOI: 10.1016/Bs.Ircmb.2019.07.002 |
0.669 |
|
| 2019 |
Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Kroemer G, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. PMID 31422903 DOI: 10.1016/J.Cmet.2019.07.010 |
0.669 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. International Journal of Cancer. PMID 31396957 DOI: 10.1002/Ijc.32616 |
0.655 |
|
| 2019 |
Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 20: e452-e463. PMID 31364597 DOI: 10.1016/S1470-2045(19)30171-8 |
0.464 |
|
| 2019 |
Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. Clockophagy is a novel selective autophagy process favoring ferroptosis. Science Advances. 5: eaaw2238. PMID 31355331 DOI: 10.1126/Sciadv.Aaw2238 |
0.484 |
|
| 2019 |
Maiuri L, Raia V, Piacentini M, Tosco A, Villella VR, Kroemer G. Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis gluten-mediated inhibition in celiac disease. Oncotarget. 10: 4492-4500. PMID 31321000 DOI: 10.18632/Oncotarget.27037 |
0.345 |
|
| 2019 |
Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism. 30: 36-50. PMID 31269428 DOI: 10.1016/J.Cmet.2019.06.001 |
0.501 |
|
| 2019 |
Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Carmona-Gutierrez D, Kroemer G. 4,4'-Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effects. Autophagy. I-3. PMID 31248332 DOI: 10.1080/15548627.2019.1632623 |
0.653 |
|
| 2019 |
Baracco EE, Castoldi F, Durand S, Enot DP, Tadic J, Kainz K, Madeo F, Chery A, Izzo V, Maiuri MC, Pietrocola F, Kroemer G. α-Ketoglutarate inhibits autophagy. Aging. PMID 31173576 DOI: 10.18632/aging.102001 |
0.596 |
|
| 2019 |
Liu P, Zhao L, Kepp O, Kroemer G. Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death. Oncoimmunology. 8: 1596652. PMID 31143519 DOI: 10.1080/2162402X.2019.1596652 |
0.395 |
|
| 2019 |
Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 8: 1591878. PMID 31143510 DOI: 10.1080/2162402X.2019.1591878 |
0.479 |
|
| 2019 |
Rao S, Mondragón L, Pranjic B, Hanada T, Stoll G, Köcher T, Zhang P, Jais A, Lercher A, Bergthaler A, Schramek D, Haigh K, Sica V, Leduc M, Modjtahedi N, ... ... Kroemer G, et al. AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Research. PMID 31133695 DOI: 10.1038/S41422-019-0181-4 |
0.65 |
|
| 2019 |
Chen R, Zeng L, Zhu S, Liu J, Zeh HJ, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D, Kang R. cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. Science Advances. 5: eaav5562. PMID 31131320 DOI: 10.1126/Sciadv.Aav5562 |
0.402 |
|
| 2019 |
Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Kroemer G, Carmona-Gutierrez D. Targeting GATA transcription factors - a novel strategy for anti-aging interventions? Microbial Cell (Graz, Austria). 6: 212-216. PMID 31114793 DOI: 10.15698/Mic2019.05.676 |
0.632 |
|
| 2019 |
Carreras-Sureda A, Jaña F, Urra H, Durand S, Mortenson DE, Sagredo A, Bustos G, Hazari Y, Ramos-Fernández E, Sassano ML, Pihán P, van Vliet AR, González-Quiroz M, Torres AK, Tapia-Rojas C, ... ... Kroemer G, et al. Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergetics. Nature Cell Biology. PMID 31110288 DOI: 10.1038/S41556-019-0329-Y |
0.329 |
|
| 2019 |
Stoll G, Kremer M, Bloy N, Joseph A, Castedo M, Meurice G, Klein C, Galluzzi L, Michels J, Kroemer G. Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 8: e1571389. PMID 31069148 DOI: 10.1080/2162402X.2019.1571389 |
0.737 |
|
| 2019 |
Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1883. PMID 30996258 DOI: 10.1038/S41467-019-09838-Y |
0.725 |
|
| 2019 |
Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, ... ... Kroemer G, et al. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell Reports. 27: 820-834.e9. PMID 30995479 DOI: 10.1016/J.Celrep.2019.03.058 |
0.802 |
|
| 2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. PMID 30962044 DOI: 10.1016/J.Tcb.2019.03.005 |
0.5 |
|
| 2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. 29: 449-451. PMID 30962043 DOI: 10.1016/j.tcb.2019.03.002 |
0.43 |
|
| 2019 |
Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Research. PMID 30948788 DOI: 10.1038/S41422-019-0164-5 |
0.462 |
|
| 2019 |
Zhang S, Wang Y, Xie W, Howe ENW, Busschaert N, Sauvat A, Leduc M, Gomes-da-Silva LC, Chen G, Martins I, Deng X, Maiuri L, Kepp O, Soussi T, Gale PA, ... ... Kroemer G, et al. Author Correction: Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux. Cell Death & Disease. 10: 301. PMID 30944306 DOI: 10.1038/S41419-019-1536-Y |
0.579 |
|
| 2019 |
Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1486. PMID 30940805 DOI: 10.1038/S41467-019-09415-3 |
0.756 |
|
| 2019 |
Messaoudene M, Mourikis TP, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, Routy B, Fluckiger A, Rusakiewicz S, Roberti MP, Cotteret S, Flament C, Poirier-Colame V, Jacquelot N, Ghiringhelli F, ... ... Kroemer G, et al. T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30924846 DOI: 10.1093/Annonc/Mdz112 |
0.67 |
|
| 2019 |
Perez-Lanzon M, Zitvogel L, Kroemer G. Failure of immunosurveillance accelerates aging. Oncoimmunology. 8: e1575117. PMID 30906669 DOI: 10.1080/2162402X.2019.1575117 |
0.317 |
|
| 2019 |
Maiuri L, Villella VR, Raia V, Kroemer G. The gliadin-CFTR connection: new perspectives for the treatment of celiac disease. Italian Journal of Pediatrics. 45: 40. PMID 30898172 DOI: 10.1186/S13052-019-0627-9 |
0.357 |
|
| 2019 |
Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis Is a Type of Autophagy-Dependent Cell Death. Seminars in Cancer Biology. PMID 30880243 DOI: 10.1016/J.Semcancer.2019.03.002 |
0.489 |
|
| 2019 |
Villella VR, Esposito S, Ferrari E, Monzani R, Tosco A, Rossin F, Castaldo A, Silano M, Marseglia GL, Romani L, Barlev NA, Piacentini M, Raia V, Kroemer G, Maiuri L. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. Cell Death & Disease. 10: 258. PMID 30874543 DOI: 10.1038/S41419-019-1500-X |
0.351 |
|
| 2019 |
Zhang S, Wang Y, Xie W, Howe ENW, Busschaert N, Sauvat A, Leduc M, Gomes-da-Silva LC, Chen G, Martins I, Deng X, Maiuri L, Kepp O, Soussi T, Gale PA, ... ... Kroemer G, et al. Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux. Cell Death & Disease. 10: 242. PMID 30858361 DOI: 10.1038/S41419-019-1474-8 |
0.636 |
|
| 2019 |
Sauvat A, Leduc M, Müller K, Kepp O, Kroemer G. ColocalizR: An open-source application for cell-based high-throughput colocalization analysis. Computers in Biology and Medicine. 107: 227-234. PMID 30852249 DOI: 10.1016/J.Compbiomed.2019.02.024 |
0.323 |
|
| 2019 |
Galluzzi L, Kroemer G. Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & Cellular Oncology. 6: 1558874. PMID 30788425 DOI: 10.1080/23723556.2018.1558874 |
0.417 |
|
| 2019 |
Carmona-Gutierrez D, Zimmermann A, Kainz K, Pietrocola F, Chen G, Maglioni S, Schiavi A, Nah J, Mertel S, Beuschel CB, Castoldi F, Sica V, Trausinger G, Raml R, Sommer C, ... ... Kroemer G, et al. The flavonoid 4,4'-dimethoxychalcone promotes autophagy-dependent longevity across species. Nature Communications. 10: 651. PMID 30783116 DOI: 10.1038/S41467-019-08555-W |
0.735 |
|
| 2019 |
Maiuri L, Villella VR, Piacentini M, Raia V, Kroemer G. Defective proteostasis in celiac disease as a new therapeutic target. Cell Death & Disease. 10: 114. PMID 30737369 DOI: 10.1038/S41419-019-1392-9 |
0.354 |
|
| 2019 |
Maiuri MC, Kroemer G. Therapeutic modulation of autophagy: which disease comes first? Cell Death and Differentiation. 26: 680-689. PMID 30728461 DOI: 10.1038/S41418-019-0290-0 |
0.389 |
|
| 2019 |
Iribarren K, Buque A, Mondragon L, Xie W, Lévesque S, Pol J, Zitvogel L, Kepp O, Kroemer G. Anticancer effects of anti-CD47 immunotherapy . Oncoimmunology. 8: 1550619. PMID 30723582 DOI: 10.1080/2162402X.2018.1550619 |
0.377 |
|
| 2019 |
Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 176: 11-42. PMID 30633901 DOI: 10.1016/J.Cell.2018.09.048 |
0.331 |
|
| 2019 |
Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 8: e1505174. PMID 30546943 DOI: 10.1080/2162402X.2018.1505174 |
0.352 |
|
| 2019 |
Castoldi F, Vacchelli E, Zitvogel L, Maiuri MC, Pietrocola F, Kroemer G. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology. 8: e1498285. PMID 30546941 DOI: 10.1080/2162402X.2018.1498285 |
0.802 |
|
| 2019 |
Humeau J, Lévesque S, Kroemer G, Pol JG. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models. Methods in Molecular Biology (Clifton, N.J.). 1884: 297-315. PMID 30465212 DOI: 10.1007/978-1-4939-8885-3_21 |
0.457 |
|
| 2019 |
Kroemer G, Zitvogel L, Galluzzi L. Victories and deceptions in tumor immunology: Stimuvax Oncoimmunology. 2: e23687. PMID 23483762 DOI: 10.4161/Onci.23687 |
0.531 |
|
| 2019 |
Kroemer G, Zitvogel L. Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy. Oncoimmunology. 1: 407-408. PMID 22754758 DOI: 10.4161/Onci.20074 |
0.308 |
|
| 2019 |
Zitvogel L, Kroemer G. OncoImmunology: a new journal at the frontier between oncology and immunology. Oncoimmunology. 1: 1-2. PMID 22720206 DOI: 10.4161/Onci.1.1.17645 |
0.379 |
|
| 2019 |
Dewitte H, Engelen Y, Lajoinie G, Gomes-da-Silva L, Versluis M, Smedt SCD, Kroemer G, Breckpot K, Lentacker I. Abstract B151: Exploring the induction of immunogenic cell death (ICD) by high-intensity focused ultrasound (HIFU) Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B151 |
0.488 |
|
| 2018 |
Rodriguez J, Zhang Y, Li T, Xie C, Sun Y, Xu Y, Zhou K, Huo K, Wang Y, Wang X, Andersson D, Ståhlberg A, Xing Q, Mallard C, Hagberg H, ... ... Kroemer G, et al. Lack of the brain-specific isoform of apoptosis-inducing factor aggravates cerebral damage in a model of neonatal hypoxia-ischemia. Cell Death & Disease. 10: 3. PMID 30584234 DOI: 10.1038/S41419-018-1250-1 |
0.335 |
|
| 2018 |
Castedo M, Obrist F, Kroemer G. Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions. Molecular & Cellular Oncology. 5: e1526004. PMID 30525097 DOI: 10.1080/23723556.2018.1526004 |
0.308 |
|
| 2018 |
Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate. Oncoimmunology. 7: e1528815. PMID 30524910 DOI: 10.1080/2162402X.2018.1528815 |
0.576 |
|
| 2018 |
Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 7: e1526250. PMID 30524908 DOI: 10.1080/2162402X.2018.1526250 |
0.471 |
|
| 2018 |
Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 7: e1511506. PMID 30524907 DOI: 10.1080/2162402X.2018.1511506 |
0.472 |
|
| 2018 |
G Pol J, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, R Clements D, Fahrner JE, Fend L, C Bell J, L Mossman K, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 7: e1503032. PMID 30524901 DOI: 10.1080/2162402X.2018.1503032 |
0.497 |
|
| 2018 |
Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, ... ... Kroemer G, et al. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. Oncoimmunology. 7: e1386826. PMID 30524877 DOI: 10.1080/2162402X.2017.1386826 |
0.398 |
|
| 2018 |
López-Soto A, Kroemer G. Cancer-Induced Endoplasmic Reticulum Stress in T Cells Subverts Immunosurveillance. Cell Metabolism. 28: 803-805. PMID 30517892 DOI: 10.1016/J.Cmet.2018.11.003 |
0.38 |
|
| 2018 |
Marchi S, Corricelli M, Branchini A, Vitto VAM, Missiroli S, Morciano G, Perrone M, Ferrarese M, Giorgi C, Pinotti M, Galluzzi L, Kroemer G, Pinton P. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth. The Embo Journal. PMID 30504268 DOI: 10.15252/Embj.201899435 |
0.516 |
|
| 2018 |
Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, ... ... Kroemer G, et al. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. The Embo Journal. PMID 30498130 DOI: 10.15252/Embj.2018100101 |
0.355 |
|
| 2018 |
Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, ... ... Kroemer G, et al. Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology. PMID 30452922 DOI: 10.1053/J.Gastro.2018.11.032 |
0.621 |
|
| 2018 |
Sixt BS, Núñez-Otero C, Kepp O, Valdivia RH, Kroemer G. Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death and Differentiation. PMID 30375511 DOI: 10.1038/S41418-018-0224-2 |
0.427 |
|
| 2018 |
Pietrocola F, Castoldi F, Kepp O, Carmona-Gutierrez D, Madeo F, Kroemer G. Spermidine reduces cancer-related mortality in humans. Autophagy. 1-4. PMID 30354939 DOI: 10.1080/15548627.2018.1539592 |
0.641 |
|
| 2018 |
Zhou H, Mondragón L, Xie W, Mauseth B, Leduc M, Sauvat A, Gomes-da-Silva LC, Forveille S, Iribarren K, Souquere S, Bezu L, Liu P, Zhao L, Zitvogel L, Sveinbjørnsson B, ... ... Kroemer G, et al. Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death & Disease. 9: 1086. PMID 30352991 DOI: 10.1038/S41419-018-1127-3 |
0.435 |
|
| 2018 |
Gomes-da-Silva LC, Jimenez AJ, Sauvat A, Xie W, Souquere S, Divoux S, Storch M, Sveinbjørnsson B, Rekdal Ø, Arnaut LG, Kepp O, Kroemer G, Perez F. Recruitment of LC3 to damaged Golgi apparatus. Cell Death and Differentiation. PMID 30349077 DOI: 10.1038/S41418-018-0221-5 |
0.382 |
|
| 2018 |
Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B. The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes. 1-5. PMID 30339501 DOI: 10.1080/19490976.2018.1527167 |
0.309 |
|
| 2018 |
Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nature Reviews. Molecular Cell Biology. PMID 30305710 DOI: 10.1038/S41580-018-0068-0 |
0.534 |
|
| 2018 |
Bárcena C, López-Otín C, Kroemer G. Methionine restriction for improving progeria: another autophagy-inducing anti-aging strategy? Autophagy. PMID 30304972 DOI: 10.1080/15548627.2018.1533059 |
0.322 |
|
| 2018 |
Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G. Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts. Oncoimmunology. 7: e1484980. PMID 30288345 DOI: 10.1080/2162402X.2018.1484980 |
0.344 |
|
| 2018 |
Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-Soto A. The hallmarks of successful anticancer immunotherapy. Science Translational Medicine. 10. PMID 30232229 DOI: 10.1126/Scitranslmed.Aat7807 |
0.51 |
|
| 2018 |
Enot DP, Vacchelli E, Jacquelot N, Zitvogel L, Kroemer G. TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves. Oncoimmunology. 7: e1462431. PMID 30228932 DOI: 10.1080/2162402X.2018.1462431 |
0.606 |
|
| 2018 |
Aranda F, Chaba K, Bloy N, Garcia P, Bordenave C, Martins I, Stoll G, Tesniere A, Kroemer G, Senovilla L. Immune effectors responsible for the elimination of hyperploid cancer cells. Oncoimmunology. 7: e1463947. PMID 30221060 DOI: 10.1080/2162402X.2018.1463947 |
0.651 |
|
| 2018 |
Gujar S, Pol JG, Kroemer G. Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies. Oncoimmunology. 7: e1442169. PMID 30221036 DOI: 10.1080/2162402X.2018.1442169 |
0.305 |
|
| 2018 |
Bonora M, Wieckowski MR, Sinclair DA, Kroemer G, Pinton P, Galluzzi L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature Reviews. Cardiology. PMID 30177752 DOI: 10.1038/S41569-018-0074-0 |
0.491 |
|
| 2018 |
Gomes-da-Silva LC, Zhao L, Arnaut LG, Kroemer G, Kepp O. Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus. Oncotarget. 9: 31169-31170. PMID 30131844 DOI: 10.18632/Oncotarget.25798 |
0.441 |
|
| 2018 |
Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen Q, Xie Y, Liu J, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Developmental Cell. PMID 30100261 DOI: 10.1016/J.Devcel.2018.07.012 |
0.363 |
|
| 2018 |
Pasquereau-Kotula E, Habault J, Kroemer G, Poyet JL. The anticancer peptide RT53 induces immunogenic cell death. Plos One. 13: e0201220. PMID 30080874 DOI: 10.1371/Journal.Pone.0201220 |
0.491 |
|
| 2018 |
Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G, Lotze MT, Zeh HJ, Kang R, Tang D. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X Activity. Current Biology : Cb. PMID 30057310 DOI: 10.1016/J.Cub.2018.05.094 |
0.422 |
|
| 2018 |
Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, Cao L, Xie M, Ran Q, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D. Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. Cell Host & Microbe. PMID 29937272 DOI: 10.1016/J.Chom.2018.05.009 |
0.382 |
|
| 2018 |
Pietrocola F, Castoldi F, Maiuri MC, Kroemer G. Aspirin-another caloric-restriction mimetic. Autophagy. PMID 29929449 DOI: 10.1080/15548627.2018.1454810 |
0.653 |
|
| 2018 |
Sica V, Kroemer G. Author Correction: IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29921919 DOI: 10.1038/S41422-018-0059-X |
0.58 |
|
| 2018 |
Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, ... ... Kroemer G, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death & Disease. 9: 716. PMID 29915308 DOI: 10.1038/S41419-018-0747-Y |
0.469 |
|
| 2018 |
Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G. Metabolic vulnerability of cisplatin-resistant cancers. The Embo Journal. PMID 29875130 DOI: 10.15252/Embj.201798597 |
0.777 |
|
| 2018 |
García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 7: e1433982. PMID 29872569 DOI: 10.1080/2162402X.2018.1433982 |
0.485 |
|
| 2018 |
Liu P, Zhao L, Loos F, Iribarren K, Kepp O, Kroemer G. Epigenetic anticancer agents cause HMGB1 release . Oncoimmunology. 7: e1431090. PMID 29872561 DOI: 10.1080/2162402X.2018.1431090 |
0.369 |
|
| 2018 |
Bezu L, Sauvat A, Humeau J, Leduc M, Kepp O, Kroemer G. eIF2α phosphorylation: A hallmark of immunogenic cell death. Oncoimmunology. 7: e1431089. PMID 29872560 DOI: 10.1080/2162402X.2018.1431089 |
0.398 |
|
| 2018 |
Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, Tang D, Kang R. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 7: e1431086. PMID 29872558 DOI: 10.1080/2162402X.2018.1431086 |
0.536 |
|
| 2018 |
Castoldi F, Pietrocola F, Maiuri MC, Kroemer G. Aspirin induces autophagy inhibition of the acetyltransferase EP300. Oncotarget. 9: 24574-24575. PMID 29872488 DOI: 10.18632/Oncotarget.25364 |
0.668 |
|
| 2018 |
Sica V, Kroemer G. IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29844577 DOI: 10.1038/S41422-018-0051-5 |
0.617 |
|
| 2018 |
Kang R, Kroemer G, Tang D. The Tumor Suppressor Protein p53 and the Ferroptosis Network. Free Radical Biology & Medicine. PMID 29800655 DOI: 10.1016/J.Freeradbiomed.2018.05.074 |
0.396 |
|
| 2018 |
Rossin F, Villella VR, D'Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, et al. TG2 regulates the heat-shock response by the post-translational modification of HSF1. Embo Reports. PMID 29752334 DOI: 10.15252/Embr.201745067 |
0.303 |
|
| 2018 |
Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nature Reviews. Clinical Oncology. PMID 29636538 DOI: 10.1038/S41571-018-0006-2 |
0.369 |
|
| 2018 |
Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science (New York, N.Y.). 359: 1366-1370. PMID 29567708 DOI: 10.1126/Science.Aar6918 |
0.321 |
|
| 2018 |
Pietrocola F, Castoldi F, Markaki M, Lachkar S, Chen G, Enot DP, Durand S, Bossut N, Tong M, Malik SA, Loos F, Dupont N, Mariño G, Abdelkader N, Madeo F, ... ... Kroemer G, et al. Aspirin Recapitulates Features of Caloric Restriction. Cell Reports. 22: 2395-2407. PMID 29490275 DOI: 10.1016/J.Celrep.2018.02.024 |
0.82 |
|
| 2018 |
Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nature Cell Biology. 20: 243-251. PMID 29476153 DOI: 10.1038/S41556-018-0042-2 |
0.501 |
|
| 2018 |
Lebeaupin C, Vallée D, Rousseau D, Patouraux S, Bonnafous S, Adam G, Luciano F, Luci C, Anty R, Iannelli A, Marchetti S, Kroemer G, Lacas-Gervais S, Tran A, Gual P, et al. Bax Inhibitor-1 protects from Non-Alcoholic Steatohepatitis by limiting IRE1α signaling. Hepatology (Baltimore, Md.). PMID 29457838 DOI: 10.1002/Hep.29847 |
0.338 |
|
| 2018 |
Zhang S, Stoll G, Pedro JMBS, Sica V, Sauvat A, Obrist F, Kepp O, Li Y, Maiuri L, Zamzami N, Kroemer G. Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR. Cell Death & Disease. 9: 191. PMID 29415993 DOI: 10.1038/S41419-017-0235-9 |
0.734 |
|
| 2018 |
Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science (New York, N.Y.). 359. PMID 29371440 DOI: 10.1126/Science.Aan2788 |
0.655 |
|
| 2018 |
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, ... ... Kroemer G, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation. PMID 29362479 DOI: 10.1038/S41418-017-0012-4 |
0.6 |
|
| 2018 |
Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S, Garcia P, Zhao L, Liu P, Zitvogel L, Senovilla L, Kepp O, Kroemer G. eIF2α phosphorylation is pathognomonic for immunogenic cell death. Cell Death and Differentiation. PMID 29358668 DOI: 10.1038/S41418-017-0044-9 |
0.401 |
|
| 2018 |
Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Kroemer G, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/Mic2018.01.607 |
0.567 |
|
| 2018 |
Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Høyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J, Jäättelä M. Correction for Gyrd-Hansen et al., "Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9". Molecular and Cellular Biology. 38. PMID 29288151 DOI: 10.1128/Mcb.00563-17 |
0.363 |
|
| 2017 |
Kroemer G, Galluzzi L. Lysosome-targeting agents in cancer therapy. Oncotarget. 8: 112168-112169. PMID 29348815 DOI: 10.18632/Oncotarget.21451 |
0.507 |
|
| 2017 |
Pitt JM, Kroemer G, Zitvogel L. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1036: 65-79. PMID 29275465 DOI: 10.1007/978-3-319-67577-0_5 |
0.465 |
|
| 2017 |
Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies. Trends in Immunology. PMID 29275092 DOI: 10.1016/J.It.2017.11.006 |
0.324 |
|
| 2017 |
Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, Wang P, Ma X, Kroemer G, Bartlett DL, Billiar TR, Lotze M, Zeh H, Kang R, Tang D. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Gastroenterology. PMID 29248440 DOI: 10.1053/J.Gastro.2017.12.004 |
0.417 |
|
| 2017 |
Ring J, Rockenfeller P, Abraham C, Tadic J, Poglitsch M, Schimmel K, Westermayer J, Schauer S, Achleitner B, Schimpel C, Moitzi B, Rechberger GN, Sigrist SJ, Carmona-Gutierrez D, Kroemer G, et al. Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin. Microbial Cell (Graz, Austria). 4: 411-422. PMID 29234670 DOI: 10.15698/Mic2017.12.603 |
0.353 |
|
| 2017 |
Rockenfeller P, Smolnig M, Diessl J, Bashir M, Schmiedhofer V, Knittelfelder O, Ring J, Franz J, Foessl I, Khan MJ, Rost R, Graier WF, Kroemer G, Zimmermann A, Carmona-Gutierrez D, et al. Diacylglycerol triggers Rim101 pathway-dependent necrosis in yeast: a model for lipotoxicity. Cell Death and Differentiation. PMID 29230001 DOI: 10.1038/S41418-017-0014-2 |
0.419 |
|
| 2017 |
Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. PMID 29219147 DOI: 10.1038/Cr.2017.155 |
0.582 |
|
| 2017 |
Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 6: e1398878. PMID 29209575 DOI: 10.1080/2162402X.2017.1398878 |
0.448 |
|
| 2017 |
Garg AD, More S, Rufo N, Mece O, Sassano ML, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 6: e1386829. PMID 29209573 DOI: 10.1080/2162402X.2017.1386829 |
0.6 |
|
| 2017 |
Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 6: e1371896. PMID 29209572 DOI: 10.1080/2162402X.2017.1371896 |
0.462 |
|
| 2017 |
Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. 8: 89527-89538. PMID 29163768 DOI: 10.18632/Oncotarget.19033 |
0.617 |
|
| 2017 |
Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 6: e1373237. PMID 29147629 DOI: 10.1080/2162402X.2017.1373237 |
0.525 |
|
| 2017 |
Fournier C, Martin F, Zitvogel L, Kroemer G, Galluzzi L, Apetoh L. Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 6: e1363139. PMID 29147628 DOI: 10.1080/2162402X.2017.1363139 |
0.544 |
|
| 2017 |
Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, ... ... Kroemer G, et al. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological Reviews. 280: 165-174. PMID 29027230 DOI: 10.1111/Imr.12582 |
0.451 |
|
| 2017 |
Kepp O, Loos F, Liu P, Kroemer G. Extracellular nucleosides and nucleotides as immunomodulators. Immunological Reviews. 280: 83-92. PMID 29027229 DOI: 10.1111/Imr.12571 |
0.461 |
|
| 2017 |
Kroemer G. Death, danger & immunity: Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses. Immunological Reviews. 280: 5-7. PMID 29027215 DOI: 10.1111/Imr.12604 |
0.363 |
|
| 2017 |
Biselli E, Agliari E, Barra A, Bertani FR, Gerardino A, De Ninno A, Mencattini A, Di Giuseppe D, Mattei F, Schiavoni G, Lucarini V, Vacchelli E, Kroemer G, Di Natale C, Martinelli E, et al. Organs on chip approach: a tool to evaluate cancer -immune cells interactions. Scientific Reports. 7: 12737. PMID 28986543 DOI: 10.1038/S41598-017-13070-3 |
0.654 |
|
| 2017 |
Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nature Reviews. Immunology. PMID 28944771 DOI: 10.1038/Nri.2017.99 |
0.497 |
|
| 2017 |
López-Soto A, Gonzalez S, López-Larrea C, Kroemer G. Immunosurveillance of Malignant Cells with Complex Karyotypes. Trends in Cell Biology. PMID 28939156 DOI: 10.1016/J.Tcb.2017.09.001 |
0.395 |
|
| 2017 |
Sixt BS, Kroemer G. Chlamydia Anti-apoptosis - A By-product of Metabolic Reprogramming? Ebiomedicine. PMID 28844411 DOI: 10.1016/J.Ebiom.2017.08.018 |
0.314 |
|
| 2017 |
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ, Kang R, Kroemer G, Tang D. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Reports. 20: 1692-1704. PMID 28813679 DOI: 10.1016/J.Celrep.2017.07.055 |
0.404 |
|
| 2017 |
Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6: e1328341. PMID 28811970 DOI: 10.1080/2162402X.2017.1328341 |
0.496 |
|
| 2017 |
Humeau J, Bravo-San Pedro JM, Vitale I, Nuñez L, Villalobos C, Kroemer G, Senovilla L. Calcium signaling and cell cycle: Progression or death. Cell Calcium. PMID 28801101 DOI: 10.1016/J.Ceca.2017.07.006 |
0.419 |
|
| 2017 |
Fernández ÁF, Bárcena C, Martínez-García GG, Tamargo-Gómez I, Suárez MF, Pietrocola F, Castoldi F, Esteban L, Sierra-Filardi E, Boya P, López-Otín C, Kroemer G, Mariño G. Autophagy couteracts weight gain, lipotoxicity and pancreatic β-cell death upon hypercaloric pro-diabetic regimens. Cell Death & Disease. 8: e2970. PMID 28771229 DOI: 10.1038/Cddis.2017.373 |
0.637 |
|
| 2017 |
Xie Y, Zhu S, Zhong M, Yang M, Sun X, Liu J, Kroemer G, Lotze M, Zeh HJ, Kang R, Tang D. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Gastroenterology. PMID 28764929 DOI: 10.1053/J.Gastro.2017.07.036 |
0.426 |
|
| 2017 |
Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nature Immunology. 18: 843-850. PMID 28722707 DOI: 10.1038/Ni.3754 |
0.628 |
|
| 2017 |
Galluzzi L, Kroemer G. Secondary Necrosis: Accidental No More. Trends in Cancer. 3: 1-2. PMID 28718422 DOI: 10.1016/J.Trecan.2016.12.001 |
0.558 |
|
| 2017 |
Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. PMID 28706153 DOI: 10.18632/oncotarget.19033 |
0.575 |
|
| 2017 |
Zhou X, Xie L, Xia L, Bergmann F, Büchler MW, Kroemer G, Hackert T, Fortunato F. RIP3 attenuates the pancreatic damage induced by deletion of ATG7. Cell Death & Disease. 8: e2918. PMID 28703808 DOI: 10.1038/Cddis.2017.313 |
0.362 |
|
| 2017 |
Galluzzi L, Kroemer G. Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 6: e1315496. PMID 28680746 DOI: 10.1080/2162402X.2017.1315496 |
0.5 |
|
| 2017 |
Stekovic S, Ruckenstuhl C, Royer P, Winkler-Hermaden C, Carmona-Gutierrez D, Fröhlich KU, Kroemer G, Madeo F. The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells. Microbial Cell (Graz, Austria). 4: 191-199. PMID 28660203 DOI: 10.15698/Mic2017.06.577 |
0.377 |
|
| 2017 |
Zhou X, Xie L, Bergmann F, Endris V, Strobel O, Büchler MW, Kroemer G, Hackert T, Fortunato F. The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis. Cell Death Discovery. 3: 17027. PMID 28660075 DOI: 10.1038/Cddiscovery.2017.27 |
0.414 |
|
| 2017 |
Galluzzi L, Kroemer G. An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 6: e1313376. PMID 28638742 DOI: 10.1080/2162402X.2017.1313376 |
0.467 |
|
| 2017 |
Vitale I, Manic G, Castedo M, Kroemer G. Caspase 2 in mitotic catastrophe: The terminator of aneuploid and tetraploid cells. Molecular & Cellular Oncology. 4: e1299274. PMID 28616577 DOI: 10.1080/23723556.2017.1299274 |
0.472 |
|
| 2017 |
Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 0. PMID 28598229 DOI: 10.1080/15548627.2017.1310356 |
0.757 |
|
| 2017 |
Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, ... ... Kroemer G, et al. Molecular definitions of autophagy and related processes. The Embo Journal. PMID 28596378 DOI: 10.15252/Embj.201796697 |
0.504 |
|
| 2017 |
Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. Embo Reports. PMID 28566520 DOI: 10.15252/Embr.201643602 |
0.482 |
|
| 2017 |
Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circulation Research. 120: 1812-1824. PMID 28546358 DOI: 10.1161/Circresaha.117.311082 |
0.518 |
|
| 2017 |
Fend L, Yamazaki T, Remy C, Fahrner C, Gantzer M, Nourtier V, Préville X, Quéméneur E, Kepp O, Adam J, Marabelle A, Pitt JM, Kroemer G, Zitvogel L. Immune checkpoint blockade, immunogenic chemotherapy or IFN-α blockade boost the local and abscopal effects of oncolytic virotherapy. Cancer Research. PMID 28536278 DOI: 10.1158/0008-5472.Can-16-2165 |
0.381 |
|
| 2017 |
Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nature Reviews. Microbiology. PMID 28529325 DOI: 10.1038/Nrmicro.2017.44 |
0.317 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery. PMID 28529316 DOI: 10.1038/Nrd.2017.22 |
0.516 |
|
| 2017 |
Stoll G, Ma Y, Yang H, Kepp O, Zitvogel L, Kroemer G. Pro-necrotic molecules impact local immunosurveillance in human breast cancer. Oncoimmunology. 6: e1299302. PMID 28507808 DOI: 10.1080/2162402X.2017.1299302 |
0.321 |
|
| 2017 |
Sun Y, Li T, Xie C, Xu Y, Zhou K, Rodriguez J, Han W, Wang X, Kroemer G, Modjtahedi N, Blomgren K, Zhu C. Haploinsufficiency in the mitochondrial protein CHCHD4 reduces brain injury in a mouse model of neonatal hypoxia-ischemia. Cell Death & Disease. 8: e2781. PMID 28492551 DOI: 10.1038/Cddis.2017.196 |
0.362 |
|
| 2017 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: Immunosuppressive cell death in cancer. Nature Reviews. Immunology. PMID 28480896 DOI: 10.1038/Nri.2017.48 |
0.558 |
|
| 2017 |
Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L. DNA Damage in Stem Cells. Molecular Cell. 66: 306-319. PMID 28475867 DOI: 10.1016/J.Molcel.2017.04.006 |
0.521 |
|
| 2017 |
Esteban-Martínez L, Sierra-Filardi E, McGreal RS, Salazar-Roa M, Mariño G, Seco E, Durand S, Enot D, Graña O, Malumbres M, Cvekl A, Cuervo AM, Kroemer G, Boya P. Programmed mitophagy is essential for the glycolytic switch during cell differentiation. The Embo Journal. PMID 28465321 DOI: 10.15252/Embj.201695916 |
0.328 |
|
| 2017 |
Fezai M, Slaymi C, Ben-Attia M, Kroemer G, Lang F, Jemaà M. Inhibition of Colon Carcinoma Cell Migration Following Treatment with Purified Venom from Lesser Weever Fish (Trachinus Vipera). Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 41: 2279-2288. PMID 28456793 DOI: 10.1159/000475646 |
0.697 |
|
| 2017 |
Galluzzi L, Kroemer G. Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 6: e1288334. PMID 28405522 DOI: 10.1080/2162402X.2017.1288334 |
0.401 |
|
| 2017 |
Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene. PMID 28394341 DOI: 10.1038/Onc.2017.78 |
0.618 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. [Autophagy, fitness and longevity]. Medecine Sciences : M/S. 33: 246-251. PMID 28367810 DOI: 10.1051/Medsci/20173303010 |
0.507 |
|
| 2017 |
Vitale I, Kroemer G. Spontaneous DNA damage propels tumorigenicity. Cell Research. PMID 28361897 DOI: 10.1038/Cr.2017.43 |
0.301 |
|
| 2017 |
Sixt BS, Valdivia RH, Kroemer G. Chlamydia trachomatis' struggle to keep its host alive. Microbial Cell (Graz, Austria). 4: 101-104. PMID 28357396 DOI: 10.15698/Mic2017.03.564 |
0.355 |
|
| 2017 |
Fend L, Rusakiewicz S, Adam J, Bastien B, Caignard A, Messaoudene M, Iribarren C, Cremer I, Marabelle A, Borg C, Semeraro M, Barraud L, Limacher JM, Eggermont A, Kroemer G, et al. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. Oncoimmunology. 6: e1163456. PMID 28197362 DOI: 10.1080/2162402X.2016.1163456 |
0.331 |
|
| 2017 |
Pietrocola F, Kroemer G. Metformin: a metabolic modulator. Oncotarget. PMID 28122334 DOI: 10.18632/Oncotarget.14794 |
0.669 |
|
| 2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Mitophagy: Permitted by Prohibitin. Current Biology : Cb. 27: R73-R76. PMID 28118594 DOI: 10.1016/J.Cub.2016.11.055 |
0.509 |
|
| 2017 |
Eisenberg T, Abdellatif M, Zimmermann A, Schroeder S, Pendl T, Harger A, Stekovic S, Schipke J, Magnes C, Schmidt A, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, Carmona-Gutierrez D, ... ... Kroemer G, et al. Dietary spermidine for lowering high blood pressure. Autophagy. 0. PMID 28118075 DOI: 10.1080/15548627.2017.1280225 |
0.613 |
|
| 2017 |
López-Soto A, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Gonzalez S. Involvement of autophagy in NK cell development and function. Autophagy. 0. PMID 28103115 DOI: 10.1080/15548627.2016.1274486 |
0.593 |
|
| 2017 |
Izzo V, Pietrocola F, Sica V, Durand S, Lachkar S, Enot D, Bravo-San Pedro JM, Chery A, Esposito S, Raia V, Maiuri L, Maiuri MC, Kroemer G. Metabolic interactions between cysteamine and epigallocatechin gallate. Cell Cycle (Georgetown, Tex.). 0. PMID 28059601 DOI: 10.1080/15384101.2016.1249550 |
0.733 |
|
| 2017 |
Pietrocola F, Demont Y, Castoldi F, Enot D, Durand S, Semeraro M, Baracco EE, Pol J, Bravo-San Pedro JM, Bordenave C, Levesque S, Humeau J, Chery A, Métivier D, Madeo F, ... ... Kroemer G, et al. Metabolic effects of fasting on human and mouse blood in vivo. Autophagy. 0. PMID 28059587 DOI: 10.1080/15548627.2016.1271513 |
0.648 |
|
| 2017 |
Senovilla L, Demont Y, Humeau J, Bloy N, Kroemer G. Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells. Methods in Molecular Biology (Clifton, N.J.). 1524: 53-64. PMID 27815895 DOI: 10.1007/978-1-4939-6603-5_3 |
0.323 |
|
| 2017 |
Moya A, Larochette N, Paquet J, Deschepper M, Bensidhoum M, Izzo V, Kroemer G, Petite H, Logeart-Avramoglou D. Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia. Stem Cells (Dayton, Ohio). 35: 181-196. PMID 27578059 DOI: 10.1002/Stem.2493 |
0.348 |
|
| 2017 |
Baurain J, Awada A, Brunsvig PF, Kristeleit R, Loirat D, Jøssang DE, Zitvogel L, Kroemer G, Marabelle A, Rekdal Ø, Sveinbjørnsson B, Wold H, Nicolaisen B, Saunders A, Spicer J. Abstract CT108: A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426) Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct108 |
0.345 |
|
| 2017 |
Mauseth B, Eike L, Shi J, Camilio K, Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, ... ... Kroemer G, et al. Abstract 5128: Induction of immunogenic cell death and tumor regression in murine animal models by a novel cytolytic compound, LTX-401 Cancer Research. 77: 5128-5128. DOI: 10.1158/1538-7445.Am2017-5128 |
0.359 |
|
| 2017 |
Fend L, Yamazaki T, Préville X, Quéméneur E, Kepp O, Adam J, Marabelle A, Pitt J, Kroemer G, Zitvogel L. Abstract 4563: Local and abscopal effects in oncolytic virotherapy are boosted by immune checkpoint blockade, immunogenic chemotherapy, or IFNAR blockade Cancer Research. 77: 4563-4563. DOI: 10.1158/1538-7445.Am2017-4563 |
0.382 |
|
| 2017 |
Zhou H, Sauvat A, Durand S, Forveille S, Yamazaki T, Souquere S, Sica V, Rekdal Ø, Kepp O, Kroemer G. Abstract 4309: Mode of action of LTX315-induced cell death Cancer Research. 77: 4309-4309. DOI: 10.1158/1538-7445.Am2017-4309 |
0.625 |
|
| 2017 |
Gomes-da-Silva L, Bezu L, Sauvat A, Zhou H, Durand S, Pierron G, Kepp O, Arnaut LG, Kroemer G. Photodynamic therapy with redaporfin induces ER stress and immunogenic cell death Photodiagnosis and Photodynamic Therapy. 17: A36-A37. DOI: 10.1016/J.Pdpdt.2017.01.081 |
0.381 |
|
| 2017 |
Noe R, Touch S, Gaboriaud C, Fučíková J, Fremeaux-Bacchi V, Kroemer G, Kepp O, Roumenina LT. Complement interaction with cells undergoing immunogenic cell death Molecular Immunology. 89: 122. DOI: 10.1016/J.Molimm.2017.06.054 |
0.416 |
|
| 2016 |
Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial Cell (Graz, Austria). 3: 101-108. PMID 28357340 DOI: 10.15698/Mic2016.03.483 |
0.581 |
|
| 2016 |
Bravo-San Pedro JM, Pietrocola F, Sica V, Izzo V, Sauvat A, Kepp O, Maiuri MC, Kroemer G, Galluzzi L. High-Throughput Quantification of GFP-LC3 Dots by Automated Fluorescence Microscopy. Methods in Enzymology. 587: 71-86. PMID 28253977 DOI: 10.1016/Bs.Mie.2016.10.022 |
0.713 |
|
| 2016 |
Sica V, Bravo-San Pedro JM, Pietrocola F, Izzo V, Maiuri MC, Kroemer G, Galluzzi L. Assessment of Glycolytic Flux and Mitochondrial Respiration in the Course of Autophagic Responses. Methods in Enzymology. 588: 155-170. PMID 28237099 DOI: 10.1016/Bs.Mie.2016.09.079 |
0.737 |
|
| 2016 |
Sixt BS, Bastidas RJ, Finethy R, Baxter RM, Carpenter VK, Kroemer G, Coers J, Valdivia RH. The Chlamydia trachomatis Inclusion Membrane Protein CpoS Counteracts STING-Mediated Cellular Surveillance and Suicide Programs. Cell Host & Microbe. PMID 28041929 DOI: 10.1016/J.Chom.2016.12.002 |
0.462 |
|
| 2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: The complement system is also important in immunogenic cell death. Nature Reviews. Immunology. PMID 28028312 DOI: 10.1038/Nri.2016.143 |
0.574 |
|
| 2016 |
Mondragón L, Kroemer G, Galluzzi L. Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 5: e1237328. PMID 27999755 DOI: 10.1080/2162402X.2016.1237328 |
0.474 |
|
| 2016 |
Kroemer G, Galluzzi L. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. PMID 27974686 DOI: 10.18632/Oncotarget.13892 |
0.516 |
|
| 2016 |
Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annual Review of Pathology. PMID 27959630 DOI: 10.1146/Annurev-Pathol-052016-100247 |
0.521 |
|
| 2016 |
Catani JP, Medrano RF, Hunger A, Del Valle P, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology. 9: 565-574. PMID 27916291 DOI: 10.1016/J.Tranon.2016.09.011 |
0.726 |
|
| 2016 |
Semeraro M, Adam J, Stoll G, Louvet E, Chaba K, Poirier-Colame V, Sauvat A, Senovilla L, Vacchelli E, Bloy N, Humeau J, Buque A, Kepp O, Zitvogel L, André F, ... ... Kroemer G, et al. The ratio of CD8(+)/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 5: e1218106. PMID 27853639 DOI: 10.1080/2162402X.2016.1218106 |
0.609 |
|
| 2016 |
Galluzzi L, Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature Reviews. Clinical Oncology. PMID 27845767 DOI: 10.1038/Nrclinonc.2016.183 |
0.58 |
|
| 2016 |
Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, Tong M, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, ... ... Kroemer G, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nature Medicine. PMID 27841876 DOI: 10.1038/Nm.4222 |
0.621 |
|
| 2016 |
Galluzzi L, Zitvogel L, Kroemer G. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research. 4: 895-902. PMID 27803050 DOI: 10.1158/2326-6066.Cir-16-0197 |
0.51 |
|
| 2016 |
Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/Blood-2016-08-731737 |
0.549 |
|
| 2016 |
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790 |
0.704 |
|
| 2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nature Reviews. Immunology. PMID 27748397 DOI: 10.1038/Nri.2016.107 |
0.589 |
|
| 2016 |
Wiraswati HL, Hangen E, Sanz AB, Lam NV, Reinhardt C, Sauvat A, Mogha A, Ortiz A, Kroemer G, Modjtahedi N. Apoptosis inducing factor (AIF) mediates lethal redox stress induced by menadione. Oncotarget. PMID 27738311 DOI: 10.18632/Oncotarget.12562 |
0.501 |
|
| 2016 |
Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CP, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, ... ... Kroemer G, et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. PMID 27717798 DOI: 10.1016/J.Immuni.2016.09.009 |
0.361 |
|
| 2016 |
Zitvogel L, Pitt JM, Daillère R, Smyth MJ, Kroemer G. Mouse models in oncoimmunology. Nature Reviews. Cancer. PMID 27687979 DOI: 10.1038/Nrc.2016.91 |
0.343 |
|
| 2016 |
Galluzzi L, Kroemer G. Aberrant ketolysis fuels hepatocellular cancer progression. Cell Research. 26: 1077-1078. PMID 27644988 DOI: 10.1038/Cr.2016.110 |
0.504 |
|
| 2016 |
Stoll G, Iribarren K, Michels J, Leary A, Zitvogel L, Cremer I, Kroemer G. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. Oncoimmunology. 5: e1177692. PMID 27622029 DOI: 10.1080/2162402X.2016.1177692 |
0.675 |
|
| 2016 |
Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, Liu P, Zhao L, Marabelle A, Zitvogel L, ... ... Kroemer G, et al. The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. PMID 27588704 DOI: 10.1038/cdd.2016.86 |
0.403 |
|
| 2016 |
Pietrocola F, Pol J, Kroemer G. Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells. Cell Cycle (Georgetown, Tex.). 15: 3327-3328. PMID 27588357 DOI: 10.1080/15384101.2016.1224797 |
0.697 |
|
| 2016 |
Missiroli S, Bonora M, Patergnani S, Poletti F, Perrone M, Gafà R, Magri E, Raimondi A, Lanza G, Tacchetti C, Kroemer G, Pandolfi PP, Pinton P, Giorgi C. PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development. Cell Reports. 16: 2415-27. PMID 27545895 DOI: 10.1016/J.Celrep.2016.07.082 |
0.449 |
|
| 2016 |
Pietrocola F, Pol J, Vacchelli E, Baracco EE, Levesque S, Castoldi F, Maiuri MC, Madeo F, Kroemer G. Autophagy induction for the treatment of cancer. Autophagy. 12: 1962-1964. PMID 27532519 DOI: 10.1080/15548627.2016.1214778 |
0.807 |
|
| 2016 |
López-Otín C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 166: 802-21. PMID 27518560 DOI: 10.1016/J.Cell.2016.07.031 |
0.427 |
|
| 2016 |
Ladoire S, Enot D, Senovilla L, Chaix M, Zitvogel L, Kroemer G. Positive impact of autophagy in human breast cancer cells on local immunosurveillance. Oncoimmunology. 5: e1174801. PMID 27471653 DOI: 10.1080/2162402X.2016.1174801 |
0.31 |
|
| 2016 |
Ladoire S, Senovilla L, Enot D, Ghiringhelli F, Poirier-Colame V, Chaba K, Erdag G, Schaefer JT, Deacon DH, Zitvogel L, Slingluff CL, Kroemer G. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. Oncoimmunology. 5: e1160193. PMID 27471635 DOI: 10.1080/2162402X.2016.1160193 |
0.327 |
|
| 2016 |
Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674 |
0.546 |
|
| 2016 |
Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A, Zitvogel L, Kepp O, Kroemer G. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 5: e1149673. PMID 27471616 DOI: 10.1080/2162402X.2016.1149673 |
0.797 |
|
| 2016 |
Baracco EE, Pietrocola F, Buqué A, Bloy N, Senovilla L, Zitvogel L, Vacchelli E, Kroemer G. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 5: e1139275. PMID 27471610 DOI: 10.1080/2162402X.2016.1139275 |
0.752 |
|
| 2016 |
Kroemer G, Galluzzi L, Zitvogel L. STAT3 inhibition for cancer therapy: Cell-autonomous effects only? Oncoimmunology. 5: e1126063. PMID 27467938 DOI: 10.1080/2162402X.2015.1126063 |
0.588 |
|
| 2016 |
Vacchelli E, Ma Y, Baracco EE, Zitvogel L, Kroemer G. Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1. Oncoimmunology. 5: e1118600. PMID 27467929 DOI: 10.1080/2162402X.2015.1118600 |
0.63 |
|
| 2016 |
Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, Levesque S, Castoldi F, Jacquelot N, Yamazaki T, Senovilla L, Marino G, Aranda F, Durand S, Sica V, ... ... Kroemer G, et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 30: 147-60. PMID 27411589 DOI: 10.1016/J.Ccell.2016.05.016 |
0.827 |
|
| 2016 |
Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, Zitvogel L. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Immunity. 44: 1255-69. PMID 27332730 DOI: 10.1016/J.Immuni.2016.06.001 |
0.325 |
|
| 2016 |
Zitvogel L, Kroemer G. Unchaining NK cell-mediated anticancer immunosurveillance. Nature Immunology. 17: 746-7. PMID 27327996 DOI: 10.1038/Ni.3471 |
0.345 |
|
| 2016 |
Galluzzi L, Buqué A, Kroemer G. Prevention of breast cancer by RANKL/RANK blockade. Cell Research. 26: 751-2. PMID 27325297 DOI: 10.1038/Cr.2016.79 |
0.445 |
|
| 2016 |
Modjtahedi N, Kroemer G. CHCHD4 links AIF to the biogenesis of respiratory chain complex I. Molecular & Cellular Oncology. 3: e1074332. PMID 27308594 DOI: 10.1080/23723556.2015.1074332 |
0.355 |
|
| 2016 |
Rockenfeller P, Carmona-Gutierrez D, Pietrocola F, Kroemer G, Madeo F. Ethanolamine: A novel anti-aging agent. Molecular & Cellular Oncology. 3: e1019023. PMID 27308532 DOI: 10.1080/23723556.2015.1019023 |
0.629 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nature Reviews. Neuroscience. 17: 467-84. PMID 27256553 DOI: 10.1038/Nrn.2016.51 |
0.499 |
|
| 2016 |
Sica V, Manic G, Kroemer G, Vitale I, Galluzzi L. Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in Molecular Biology (Clifton, N.J.). 1417: 231-45. PMID 27221495 DOI: 10.1007/978-1-4939-3566-6_17 |
0.693 |
|
| 2016 |
Galluzzi L, Kroemer G. A four-lane highway to cancer. Nature Reviews. Molecular Cell Biology. 17: 398. PMID 27220642 DOI: 10.1038/Nrm.2016.73 |
0.453 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Defective Autophagy Initiates Malignant Transformation. Molecular Cell. 62: 473-4. PMID 27203173 DOI: 10.1016/J.Molcel.2016.05.001 |
0.483 |
|
| 2016 |
Vacchelli E, Enot DP, Pietrocola F, Zitvogel L, Kroemer G. Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy. Cancer Research. 76: 3122-6. PMID 27197163 DOI: 10.1158/0008-5472.Can-16-0294 |
0.759 |
|
| 2016 |
Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in Cell Biology. 26: 655-67. PMID 27161573 DOI: 10.1016/J.Tcb.2016.04.006 |
0.7 |
|
| 2016 |
Tortola L, Nitsch R, Bertrand MJ, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, ... ... Kroemer G, et al. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Reports. PMID 27160902 DOI: 10.1016/J.Celrep.2016.04.032 |
0.326 |
|
| 2016 |
Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631 |
0.492 |
|
| 2016 |
Marabelle A, Routy B, Michels J, Kroemer G, Zitvogel L. Prime time for immune-checkpoint targeted therapy at ASCO 2015. Oncoimmunology. 5: e1068494. PMID 27141332 DOI: 10.1080/2162402X.2015.1068494 |
0.663 |
|
| 2016 |
Sica V, Maiuri MC, Kroemer G, Galluzzi L. Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1419: 1-16. PMID 27108427 DOI: 10.1007/978-1-4939-3581-9_1 |
0.74 |
|
| 2016 |
Galluzzi L, Kroemer G. Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 7: 29877-8. PMID 27105494 DOI: 10.18632/Oncotarget.8841 |
0.568 |
|
| 2016 |
Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27069014 DOI: 10.1093/Annonc/Mdw168 |
0.343 |
|
| 2016 |
Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell. 165: 276-87. PMID 27058662 DOI: 10.1016/J.Cell.2016.03.001 |
0.346 |
|
| 2016 |
Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, et al. Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 5: e1117740. PMID 27057469 DOI: 10.1080/2162402X.2015.1117740 |
0.412 |
|
| 2016 |
Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942 |
0.701 |
|
| 2016 |
Ladoire S, Enot D, Andre F, Zitvogel L, Kroemer G. Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. Oncoimmunology. 5: e1082706. PMID 27057465 DOI: 10.1080/2162402X.2015.1082706 |
0.436 |
|
| 2016 |
Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. Improvement of immunogenic chemotherapy by STAT3 inhibition. Oncoimmunology. 5: e1078061. PMID 27057456 DOI: 10.1080/2162402X.2015.1078061 |
0.674 |
|
| 2016 |
Stoll G, Zitvogel L, Kroemer G. Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis. Oncoimmunology. 5: e1067746. PMID 27057431 DOI: 10.1080/2162402X.2015.1067746 |
0.348 |
|
| 2016 |
Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G. Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells. Oncoimmunology. 5: e1064581. PMID 27057430 DOI: 10.1080/2162402X.2015.1064581 |
0.636 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kepp O, Kroemer G. Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences : Cmls. 73: 2405-10. PMID 27048813 DOI: 10.1007/S00018-016-2209-Y |
0.565 |
|
| 2016 |
Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. The Journal of Clinical Investigation. 126: 1224-32. PMID 27035813 DOI: 10.1172/Jci81137 |
0.384 |
|
| 2016 |
Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. The Journal of Clinical Investigation. 126: 1139-43. PMID 27035805 DOI: 10.1172/Jci87316 |
0.39 |
|
| 2016 |
Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, ... ... Kroemer G, et al. A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death and Differentiation. PMID 27035618 DOI: 10.1038/Cdd.2016.22 |
0.337 |
|
| 2016 |
Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier-Colame V, Chaba K, Semeraro M, Chaix M, Penault-Llorca F, Arnould L, Poillot ML, Arveux P, Delaloge S, Andre F, Zitvogel L, ... Kroemer G, et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy. 12: 864-75. PMID 26979828 DOI: 10.1080/15548627.2016.1154244 |
0.337 |
|
| 2016 |
Zhou H, Forveille S, Sauvat A, Yamazaki T, Senovilla L, Ma Y, Liu P, Yang H, Bezu L, Müller K, Zitvogel L, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 triggers immunogenic cell death. Cell Death & Disease. 7: e2134. PMID 26962684 DOI: 10.1038/cddis.2016.47 |
0.389 |
|
| 2016 |
Pol J, Kroemer G, Galluzzi L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 5: e1115641. PMID 26942095 DOI: 10.1080/2162402X.2015.1115641 |
0.429 |
|
| 2016 |
Galluzzi L, Eggermont A, Kroemer G. Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 5: e1106127. PMID 26942094 DOI: 10.1080/2162402X.2015.1106127 |
0.433 |
|
| 2016 |
Ma Y, Yang H, Pitt JM, Kroemer G, Zitvogel L. Therapy-induced microenvironmental changes in cancer. Journal of Molecular Medicine (Berlin, Germany). PMID 26931513 DOI: 10.1007/S00109-016-1401-8 |
0.406 |
|
| 2016 |
Mollereau B, Rzechorzek NM, Roussel BD, Sedru M, Van den Brink D, Bailly-Maitre B, Palladino F, Medinas DB, Domingos PM, Hunot S, Chandran S, Birman S, Baron T, Vivien D, Duarte CB, ... ... Kroemer G, et al. Adaptive Preconditioning in Neurological Diseases - Therapeutic Insights from Proteostatic Perturbations. Brain Research. PMID 26923166 DOI: 10.1016/J.Brainres.2016.02.033 |
0.335 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Kroemer G, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886 |
0.76 |
|
| 2016 |
Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 44: 221-31. PMID 26885855 DOI: 10.1016/J.Immuni.2016.01.020 |
0.605 |
|
| 2016 |
Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C, Lupo A, Fridman WH, Dieu-Nosjean MC, Kroemer G, Sautès-Fridman C, et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Research. 76: 1746-56. PMID 26842877 DOI: 10.1158/0008-5472.Can-15-1142 |
0.411 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Kroemer G, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.801 |
|
| 2016 |
Modjtahedi N, Tokatlidis K, Dessen P, Kroemer G. Mitochondrial Proteins Containing Coiled-Coil-Helix-Coiled-Coil-Helix (CHCH) Domains in Health and Disease. Trends in Biochemical Sciences. 41: 245-60. PMID 26782138 DOI: 10.1016/J.Tibs.2015.12.004 |
0.331 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in Cell Biology. 26: 1-3. PMID 26612212 DOI: 10.1016/J.Tcb.2015.11.001 |
0.586 |
|
| 2016 |
Hermanova I, Arruabarrena-Aristorena A, Valis K, Nuskova H, Alberich-Jorda M, Fiser K, Fernandez-Ruiz S, Kavan D, Pecinova A, Niso-Santano M, Zaliova M, Novak P, Houstek J, Mracek T, Kroemer G, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells Leukemia. 30: 209-218. PMID 26239197 DOI: 10.1038/leu.2015.213 |
0.334 |
|
| 2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis. Cell Death and Differentiation. 22: 1237-8. PMID 26143748 DOI: 10.1038/Cdd.2015.54 |
0.461 |
|
| 2016 |
Kroemer G. Abstract IA15: Microbiota and cancer immunosurveillance: An introduction Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-Ia15 |
0.331 |
|
| 2016 |
Yamazaki T, Vetizou M, Flores C, Marabelle A, Sveinbjørnsson B, Rekdal Ø, Kroemer G, Zitvogel L. Abstract 2326: LTX-315, an oncolytic peptide, increases anticancer immunity mediated by CTLA4 blockade in an interleukin-2 receptor beta-chain-dependent manner Cancer Research. 76: 2326-2326. DOI: 10.1158/1538-7445.Am2016-2326 |
0.357 |
|
| 2016 |
Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis Immunity. 44: 221-231. DOI: 10.1016/j.immuni.2016.01.020 |
0.505 |
|
| 2015 |
Vitale I, Manic G, Senovilla L, Kroemer G, Galluzzi L. Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in Cancer. 1: 124-135. PMID 28741522 DOI: 10.1016/J.Trecan.2015.08.001 |
0.547 |
|
| 2015 |
Obrist F, Manic G, Kroemer G, Vitale I, Galluzzi L. Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology. 2: e974463. PMID 27308423 DOI: 10.4161/23723556.2014.974463 |
0.549 |
|
| 2015 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 28: 690-714. PMID 26678337 DOI: 10.1016/J.Ccell.2015.10.012 |
0.531 |
|
| 2015 |
Jemaà M, Manic G, Lledo G, Lissa D, Reynes C, Morin N, Chibon F, Sistigu A, Castedo M, Vitale I, Kroemer G, Abrieu A. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget. PMID 26637805 DOI: 10.18632/Oncotarget.6432 |
0.842 |
|
| 2015 |
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, ... ... Kroemer G, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. 6: 588. PMID 26635802 DOI: 10.3389/Fimmu.2015.00588 |
0.749 |
|
| 2015 |
Galluzzi L, Kroemer G. Defective autophagy gets to the brain. Oncotarget. 6: 39396-7. PMID 26575951 DOI: 10.18632/Oncotarget.6318 |
0.564 |
|
| 2015 |
Forveille S, Zhou H, Sauvat A, Bezu L, Müller K, Liu P, Zitvogel L, Pierron G, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle (Georgetown, Tex.). 14: 3506-12. PMID 26566869 DOI: 10.1080/15384101.2015.1093710 |
0.398 |
|
| 2015 |
Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, ... ... Kroemer G, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, N.Y.). PMID 26541610 DOI: 10.1126/Science.Aad1329 |
0.307 |
|
| 2015 |
Galluzzi L, Pietrocola F, Kroemer G. Molecular Regulation of Circadian Rhythms by Polyamines. Cell Metabolism. 22: 757-8. PMID 26536485 DOI: 10.1016/J.Cmet.2015.10.007 |
0.67 |
|
| 2015 |
Bloy N, Sauvat A, Chaba K, Buqué A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 6: 41204-15. PMID 26517677 DOI: 10.18632/Oncotarget.5400 |
0.4 |
|
| 2015 |
Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, ... ... Kroemer G, et al. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science (New York, N.Y.). PMID 26516201 DOI: 10.1126/Science.Aad0779 |
0.811 |
|
| 2015 |
Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, ... ... Kroemer G, et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy. 11: 1878-90. PMID 26506894 DOI: 10.1080/15548627.2015.1082022 |
0.313 |
|
| 2015 |
Seah S, Low IC, Hirpara JL, Sachaphibulkij K, Kroemer G, Brenner C, Pervaiz S. Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells. Cell Death & Disease. 6: e1926. PMID 26492363 DOI: 10.1038/Cddis.2015.299 |
0.431 |
|
| 2015 |
Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673 |
0.55 |
|
| 2015 |
Semeraro M, Rusakiewicz S, Zitvogel L, Kroemer G. Natural killer cell mediated immunosurveillance of pediatric neuroblastoma. Oncoimmunology. 4: e1042202. PMID 26451315 DOI: 10.1080/2162402X.2015.1042202 |
0.365 |
|
| 2015 |
Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21: 1128-38. PMID 26444637 DOI: 10.1038/Nm.3944 |
0.518 |
|
| 2015 |
Vacchelli E, Sistigu A, Yamazaki T, Vitale I, Zitvogel L, Kroemer G. Autocrine signaling of type 1 interferons in successful anticancer chemotherapy. Oncoimmunology. 4: e988042. PMID 26405588 DOI: 10.4161/2162402X.2014.988042 |
0.686 |
|
| 2015 |
Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 20: 1666-7. PMID 26400497 DOI: 10.1007/S10495-015-1154-9 |
0.813 |
|
| 2015 |
Michels J, Adam J, Goubar A, Obrist F, Damotte D, Robin A, Alifano M, Vitale I, Olaussen KA, Girard P, Cremer I, Castedo M, Soria JC, Kroemer G. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 26: 2470-7. PMID 26387143 DOI: 10.1093/Annonc/Mdv393 |
0.696 |
|
| 2015 |
Zhou H, Forveille S, Sauvat A, Sica V, Izzo V, Durand S, Müller K, Liu P, Zitvogel L, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. Oncotarget. PMID 26378049 DOI: 10.18632/Oncotarget.5613 |
0.636 |
|
| 2015 |
Piacentini M, Kroemer G. Dying to survive - apoptosis, necroptosis, autophagy as supreme experiments of nature. The International Journal of Developmental Biology. 59: 5-9. PMID 26374520 DOI: 10.1387/ijdb.150167mp |
0.352 |
|
| 2015 |
Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C, Goéré D, Mariette C, Zitvogel L, Kroemer G. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget. 6: 20840-50. PMID 26369701 DOI: 10.18632/Oncotarget.4428 |
0.653 |
|
| 2015 |
Zitvogel L, Kroemer G. Subversion of anticancer immunosurveillance by radiotherapy. Nature Immunology. 16: 1005-7. PMID 26343538 DOI: 10.1038/Ni.3236 |
0.33 |
|
| 2015 |
Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/Fimmu.2015.00402 |
0.555 |
|
| 2015 |
Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G. Organelle-Specific Initiation of Autophagy. Molecular Cell. 59: 522-39. PMID 26295960 DOI: 10.1016/J.Molcel.2015.07.021 |
0.694 |
|
| 2015 |
Gentili M, Kowal J, Tkach M, Satoh T, Lahaye X, Conrad C, Boyron M, Lombard B, Durand S, Kroemer G, Loew D, Dalod M, Théry C, Manel N. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science (New York, N.Y.). PMID 26229115 DOI: 10.1126/Science.Aab3628 |
0.33 |
|
| 2015 |
Zitvogel L, Kroemer G. CANCER. A p53-regulated immune checkpoint relevant to cancer. Science (New York, N.Y.). 349: 476-7. PMID 26228128 DOI: 10.1126/Science.Aac8475 |
0.387 |
|
| 2015 |
Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. STAT3 inhibition enhances the therapeutic efficacy of immunogenic chemotherapy by stimulating type 1 interferon production by cancer cells. Cancer Research. PMID 26208907 DOI: 10.1158/0008-5472.Can-15-1122 |
0.665 |
|
| 2015 |
Modjtahedi N, Hangen E, Gonin P, Kroemer G. Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4. Cell Cycle (Georgetown, Tex.). 14: 2743-7. PMID 26178476 DOI: 10.1080/15384101.2015.1068477 |
0.362 |
|
| 2015 |
Kroemer G, Galluzzi L. Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 4: e1008853. PMID 26155425 DOI: 10.1080/2162402X.2015.1008853 |
0.513 |
|
| 2015 |
Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531 |
0.479 |
|
| 2015 |
Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 4: e1058597. PMID 26140250 DOI: 10.1080/2162402X.2015.1058597 |
0.474 |
|
| 2015 |
Kroemer G, Galluzzi L. Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 4: e1058037. PMID 26140249 DOI: 10.1080/2162402X.2015.1058037 |
0.469 |
|
| 2015 |
Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 4: e974411. PMID 26137405 DOI: 10.4161/2162402X.2014.974411 |
0.411 |
|
| 2015 |
Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866 |
0.747 |
|
| 2015 |
Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814 |
0.511 |
|
| 2015 |
Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G. Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle (Georgetown, Tex.). 14: 2399-407. PMID 26098646 DOI: 10.1080/15384101.2015.1064206 |
0.772 |
|
| 2015 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Necrosis: Linking the Inflammasome to Inflammation. Cell Reports. 11: 1501-2. PMID 26082972 DOI: 10.1016/J.Celrep.2015.05.041 |
0.523 |
|
| 2015 |
Bezu L, Gomes-da-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in Immunology. 6: 275. PMID 26082782 DOI: 10.3389/Fimmu.2015.00275 |
0.525 |
|
| 2015 |
Stoll G, Bindea G, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget. 6: 11894-909. PMID 26059437 DOI: 10.18632/Oncotarget.4180 |
0.329 |
|
| 2015 |
Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabolism. 21: 805-21. PMID 26039447 DOI: 10.1016/J.Cmet.2015.05.014 |
0.679 |
|
| 2015 |
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nature Reviews. Immunology. 15: 405-14. PMID 26027717 DOI: 10.1038/Nri3845 |
0.49 |
|
| 2015 |
Hangen E, Féraud O, Lachkar S, Mou H, Doti N, Fimia GM, Lam NV, Zhu C, Godin I, Muller K, Chatzi A, Nuebel E, Ciccosanti F, Flamant S, Bénit P, ... ... Kroemer G, et al. Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis. Molecular Cell. 58: 1001-14. PMID 26004228 DOI: 10.1016/J.Molcel.2015.04.020 |
0.441 |
|
| 2015 |
Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers in Immunology. 6: 187. PMID 25964783 DOI: 10.3389/Fimmu.2015.00187 |
0.59 |
|
| 2015 |
Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940 |
0.718 |
|
| 2015 |
Zitvogel L, Kroemer G. Cancer: Antibodies regulate antitumour immunity. Nature. 521: 35-7. PMID 25924066 DOI: 10.1038/Nature14388 |
0.418 |
|
| 2015 |
Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, ... ... Kroemer G, et al. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Science Translational Medicine. 7: 283ra55. PMID 25877893 DOI: 10.1126/Scitranslmed.Aaa2327 |
0.31 |
|
| 2015 |
Sauvat A, Wang Y, Segura F, Spaggiari S, Müller K, Zhou H, Galluzzi L, Kepp O, Kroemer G. Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 6: 9467-75. PMID 25816366 DOI: 10.18632/Oncotarget.3266 |
0.665 |
|
| 2015 |
Bonora M, Wieckowsk MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 34: 1608. PMID 25790189 DOI: 10.1038/Onc.2014.462 |
0.466 |
|
| 2015 |
Kroemer G, Bravo-San Pedro JM, Galluzzi L. Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum. Cell Death & Disease. 6: e1698. PMID 25789973 DOI: 10.1038/Cddis.2015.70 |
0.487 |
|
| 2015 |
Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, van Leeuwen FW, Kroemer G, et al. Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin. Cell Reports. PMID 25753421 DOI: 10.1016/J.Celrep.2015.02.009 |
0.395 |
|
| 2015 |
Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. PMID 25749194 DOI: 10.1016/J.Semcancer.2015.02.004 |
0.53 |
|
| 2015 |
Pedro JM, Wei Y, Sica V, Maiuri MC, Zou Z, Kroemer G, Levine B. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 11: 452-9. PMID 25715028 DOI: 10.1080/15548627.2015.1017191 |
0.687 |
|
| 2015 |
Niso-Santano M, Bravo-San Pedro JM, Maiuri MC, Tavernarakis N, Cecconi F, Madeo F, Codogno P, Galluzzi L, Kroemer G. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 11: 575-7. PMID 25714112 DOI: 10.1080/15548627.2015.1017222 |
0.481 |
|
| 2015 |
Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, ... ... Kroemer G, et al. Autophagy in malignant transformation and cancer progression. The Embo Journal. 34: 856-80. PMID 25712477 DOI: 10.15252/Embj.201490784 |
0.751 |
|
| 2015 |
Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. The Journal of Clinical Investigation. 125: 85-93. PMID 25654554 DOI: 10.1172/Jci73946 |
0.369 |
|
| 2015 |
Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. The Journal of Clinical Investigation. 125: 1-4. PMID 25654544 DOI: 10.1172/Jci78652 |
0.415 |
|
| 2015 |
Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine. 7: 271ps1. PMID 25609166 DOI: 10.1126/Scitranslmed.3010473 |
0.471 |
|
| 2015 |
Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mariño G, Cianfanelli V, Ben-Younès A, Troncoso R, Markaki M, Sica V, Izzo V, Chaba K, Bauvy C, Dupont N, Kepp O, ... ... Kroemer G, et al. Unsaturated fatty acids induce non-canonical autophagy. The Embo Journal. 34: 1025-41. PMID 25586377 DOI: 10.15252/Embj.201489363 |
0.822 |
|
| 2015 |
Rockenfeller P, Koska M, Pietrocola F, Minois N, Knittelfelder O, Sica V, Franz J, Carmona-Gutierrez D, Kroemer G, Madeo F. Phosphatidylethanolamine positively regulates autophagy and longevity. Cell Death and Differentiation. 22: 499-508. PMID 25571976 DOI: 10.1038/Cdd.2014.219 |
0.753 |
|
| 2015 |
Maiuri MC, Kroemer G. Essential role for oxidative phosphorylation in cancer progression. Cell Metabolism. 21: 11-2. PMID 25565201 DOI: 10.1016/J.Cmet.2014.12.013 |
0.339 |
|
| 2015 |
Pietrocola F, Lachkar S, Enot DP, Niso-Santano M, Bravo-San Pedro JM, Sica V, Izzo V, Maiuri MC, Madeo F, Mariño G, Kroemer G. Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death and Differentiation. 22: 509-16. PMID 25526088 DOI: 10.1038/Cdd.2014.215 |
0.758 |
|
| 2015 |
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, ... ... Kroemer G, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death and Differentiation. 22: 58-73. PMID 25236395 DOI: 10.1038/Cdd.2014.137 |
0.607 |
|
| 2014 |
Ruckenstuhl C, Netzberger C, Entfellner I, Carmona-Gutierrez D, Kickenweiz T, Stekovic S, Gleixner C, Schmid C, Klug L, Hajnal I, Sorgo AG, Eisenberg T, Büttner S, Marin O G, Koziel R, ... ... Kroemer G, et al. Autophagy extends lifespan via vacuolar acidification. Microbial Cell (Graz, Austria). 1: 160-162. PMID 28357240 DOI: 10.15698/Mic2014.05.147 |
0.31 |
|
| 2014 |
Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e977612. PMID 27308338 DOI: 10.4161/23723556.2014.977612 |
0.331 |
|
| 2014 |
Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology. 1: e29911. PMID 27308318 DOI: 10.4161/Mco.29911 |
0.584 |
|
| 2014 |
Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e29052. PMID 27308308 DOI: 10.4161/Mco.29052 |
0.567 |
|
| 2014 |
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, ... ... Kroemer G, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 3: e955691. PMID 25941621 DOI: 10.4161/21624011.2014.955691 |
0.827 |
|
| 2014 |
Aranda F, Bloy N, Galluzzi L, Kroemer G, Senovilla L. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 3: e955685. PMID 25941619 DOI: 10.4161/21624011.2014.955685 |
0.537 |
|
| 2014 |
Bloy N, Pol J, Manic G, Vitale I, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 3: e954929. PMID 25941606 DOI: 10.4161/21624011.2014.954929 |
0.496 |
|
| 2014 |
Galluzzi L, Kroemer G, Eggermont A. Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 3: e967147. PMID 25941597 DOI: 10.4161/21624011.2014.967147 |
0.496 |
|
| 2014 |
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424 |
0.453 |
|
| 2014 |
Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994 |
0.714 |
|
| 2014 |
Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology. 3: e944047. PMID 25610726 DOI: 10.4161/21624011.2014.944047 |
0.422 |
|
| 2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Kroemer G, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998 |
0.696 |
|
| 2014 |
Zitvogel L, Kroemer G. CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance. Cancer Cell. 26: 591-3. PMID 25517740 DOI: 10.1016/J.Ccell.2014.10.008 |
0.387 |
|
| 2014 |
Bonora M, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Pinton P. Novel insights into the mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 13: 2666-70. PMID 25486353 DOI: 10.4161/15384101.2014.949082 |
0.532 |
|
| 2014 |
Mariño G, Pietrocola F, Madeo F, Kroemer G. Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers. Autophagy. 10: 1879-82. PMID 25484097 DOI: 10.4161/Auto.36413 |
0.666 |
|
| 2014 |
Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 159: 1263-76. PMID 25480292 DOI: 10.1016/J.Cell.2014.11.006 |
0.687 |
|
| 2014 |
De Stefano D, Villella VR, Esposito S, Tosco A, Sepe A, De Gregorio F, Salvadori L, Grassia R, Leone CA, De Rosa G, Maiuri MC, Pettoello-Mantovani M, Guido S, Bossi A, Zolin A, ... ... Kroemer G, et al. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy. 10: 2053-74. PMID 25350163 DOI: 10.4161/15548627.2014.973737 |
0.328 |
|
| 2014 |
Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, ... ... Kroemer G, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nature Medicine. 20: 1301-9. PMID 25344738 DOI: 10.1038/Nm.3708 |
0.659 |
|
| 2014 |
Kroemer G, Perfettini JL. Entosis, a key player in cancer cell competition. Cell Research. 24: 1280-1. PMID 25342563 DOI: 10.1038/Cr.2014.133 |
0.391 |
|
| 2014 |
Zitvogel L, Kroemer G. Cytokines reinstate NK cell-mediated cancer immunosurveillance. The Journal of Clinical Investigation. 124: 4687-9. PMID 25329691 DOI: 10.1172/Jci78531 |
0.313 |
|
| 2014 |
Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 345: 1250256. PMID 25237106 DOI: 10.1126/Science.1250256 |
0.561 |
|
| 2014 |
Loriot Y, Mordant P, Dugue D, Geneste O, Gombos A, Opolon P, Guegan J, Perfettini JL, Pierre A, Berthier LK, Kroemer G, Soria JC, Depil S, Deutsch E. Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer. Cell Death & Disease. 5: e1423. PMID 25232677 DOI: 10.1038/cddis.2014.365 |
0.319 |
|
| 2014 |
Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Caloric restriction mimetics: towards a molecular definition. Nature Reviews. Drug Discovery. 13: 727-40. PMID 25212602 DOI: 10.1038/Nrd4391 |
0.616 |
|
| 2014 |
Michels J, Obrist F, Castedo M, Vitale I, Kroemer G. PARP and other prospective targets for poisoning cancer cell metabolism. Biochemical Pharmacology. 92: 164-71. PMID 25199458 DOI: 10.1016/J.Bcp.2014.08.026 |
0.716 |
|
| 2014 |
Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget. 5: 5190-1. PMID 25114034 DOI: 10.18632/Oncotarget.2266 |
0.472 |
|
| 2014 |
Michels J, Obrist F, Vitale I, Lissa D, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Castedo M, Kroemer G. MCL-1 dependency of cisplatin-resistant cancer cells. Biochemical Pharmacology. 92: 55-61. PMID 25107702 DOI: 10.1016/J.Bcp.2014.07.029 |
0.816 |
|
| 2014 |
Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/Onci.28694 |
0.536 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/Onci.29179 |
0.69 |
|
| 2014 |
Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/Onci.29030 |
0.706 |
|
| 2014 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nature Cell Biology. 16: 728-36. PMID 25082195 DOI: 10.1038/Ncb3005 |
0.594 |
|
| 2014 |
Aranda F, Bloy N, Pesquet J, Petit B, Chaba K, Sauvat A, Kepp O, Khadra N, Enot D, Pfirschke C, Pittet M, Zitvogel L, Kroemer G, Senovilla L. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer. Oncogene. 34: 3053-62. PMID 25065595 DOI: 10.1038/Onc.2014.234 |
0.398 |
|
| 2014 |
Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 3: e28473. PMID 25050214 DOI: 10.4161/Onci.28473 |
0.835 |
|
| 2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344 |
0.673 |
|
| 2014 |
Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O, Kroemer G. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology. 3: e28276. PMID 25050202 DOI: 10.4161/Onci.28276 |
0.794 |
|
| 2014 |
Senovilla L, Aranda F, Galluzzi L, Kroemer G. Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current Opinion in Immunology. 30: 24-31. PMID 24950501 DOI: 10.1016/J.Coi.2014.05.009 |
0.571 |
|
| 2014 |
Galluzzi L, Kroemer G. Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in Enzymology. 543: xv-xix. PMID 24924141 DOI: 10.1016/B978-0-12-801329-8.10000-5 |
0.408 |
|
| 2014 |
Scoazec M, Durand S, Chery A, Galluzzi L, Kroemer G. Metabolomic profiling of cultured cancer cells. Methods in Enzymology. 543: 165-78. PMID 24924132 DOI: 10.1016/B978-0-12-801329-8.00008-8 |
0.501 |
|
| 2014 |
Nassif M, Valenzuela V, Rojas-Rivera D, Vidal R, Matus S, Castillo K, Fuentealba Y, Kroemer G, Levine B, Hetz C. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 10: 1256-71. PMID 24905722 DOI: 10.4161/Auto.28784 |
0.329 |
|
| 2014 |
Schroeder S, Pendl T, Zimmermann A, Eisenberg T, Carmona-Gutierrez D, Ruckenstuhl C, Mariño G, Pietrocola F, Harger A, Magnes C, Sinner F, Pieber TR, Dengjel J, Sigrist SJ, Kroemer G, et al. Acetyl-coenzyme A: a metabolic master regulator of autophagy and longevity. Autophagy. 10: 1335-7. PMID 24904996 DOI: 10.4161/Auto.28919 |
0.669 |
|
| 2014 |
Troncoso R, Paredes F, Parra V, Gatica D, Vásquez-Trincado C, Quiroga C, Bravo-Sagua R, López-Crisosto C, Rodriguez AE, Oyarzún AP, Kroemer G, Lavandero S. Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance. Cell Cycle (Georgetown, Tex.). 13: 2281-95. PMID 24897381 DOI: 10.4161/Cc.29272 |
0.399 |
|
| Show low-probability matches. |